H. No. 5 6 1 6 S. No. 2436
Begun and held in IVletro Manila, on Monday, the twenty-seventh day of July, two thousand fifteen.
[ R E P U B L I C A C T NO .10918 I
A N A C T R E G U L A T I N G A N D M O D E R N I Z I N G T H E P R A C H C E
O F P H A R M A C Y I N T H E P H I L I P P I N E S , R E P E A L I N G
F O R T H E P U R P O S E R E P U B L I C A C T N U M B E R E D
F I V E T H O U S A N D N I N E H U N D R E D T W E N T Y - O N E
( R . A . N O . 5 9 2 1 ) , O T H E R W I S E K N O W N A S T H E
P H A R M A C Y L A W
B e it e n a c t e d b y the S e n a t e and H o u s e o f R e p r e s e n t a t i v e s o f the Philippines in C o n g r e s s assembled:
A R T I C L E I
G E N E R A L P R O V I S I O N S
S E C T I O N 1 . T i t l e . - T h i s A c t s h a l l b e k n o w n a s t h e " P h i l i p p i n e P h a r m a c y A c t " .
S E C . 2 . S t a t e m e n t o f P o l i c y . - T h e S t a t e r e c o g n i z e s t h e v i t a l r o l e o f p h a r m a c i s t s i n t h e d e l i v e r y o f q u a l i t y h e a l t h c a r e s e r v i c e s t h r o n g t h e p r o v i s i o n o f s a f e , e f f e c t i v e , a n d q u a l i t y
2
phar
mace
utic
al pr
oduc
ts,
phar
mace
utic
al ca
re,
drug
in
form
atio
n,
patient
medication
coun
seli
ng,
and
health
promotion.The
phar
maci
sts'
pr
ofes
sion
al se
rvic
es
shall,
ther
efor
e, be
pr
omot
ed
as an
indi
spen
sabl
e co
mpon
ent
of t
he
tota
l health
care
sy
stem
to
en
sure
the
phys
ical
we
ll-b
eing
of
the
Fi
lipi
nos.
.
Henc
e,
the
State
shall
develop
and
nurture
comp
eten
t,
prod
ucti
ve,
mora
lly
upri
ght,
and
weU
-roi
mded
ph
arma
cist
s wh
ose
stan
dard
s of
pro
fess
iona
l pr
acti
ce and
serv
ice
shall be
ex
cell
ent
and
glob
ally
co
mpet
itiv
e th
roug
h re
gula
tory
mea
sure
s,
prog
rams
, and
activities
that
promote
and
sustain
their
continuing
prof
essi
onal
de
velo
pmen
t.
SEC.
3.
Objec
tives
. -
This
Act
pro
vide
s fo
r an
d sh
all
gove
rn
the:
(a)
Stan
dard
izat
ion
and
regi
dati
on o
f ph
arma
cy
educ
atio
n;
(b)
Admi
nist
rati
on o
f li
cens
ure
exam
inat
ion,
reg
istr
atio
n,
and
lice
nsin
g of
ph
arma
cist
s;
\ (c
) Su
perv
isio
n, c
ontr
ol,
and
regulation
of t
he
prac
tice
of
pharmacy
in
the
Phih
ppin
es;
(d)
Development
and
enhancement
of
professional
competence
of pl
iair
maci
sts
through
continuing
prof
essi
onal
de
velo
pmen
t,
rese
arch
, and
othe
r re
late
d ac
tivi
ties
; and
(e)
Inte
grat
ion
of t
he pharmacy
prof
essi
on.
SEC.
4.
Sco
peo
f th
e P
ract
ice
of P
ha
rma
cy
. -
A pe
rson
is
deemed
to
be pr
acti
cing
ph
arma
cy,
within
the
meaning
of this
Act,
when
with
or without
a fe
e,
sala
ry,
perc
enta
ge
or
othe
r re
ward
s, pa
id or
gi
ven
dire
ctly
or
indi
rect
ly,
shall:
(a)
Prep
are,
co
mpou
nd
or manufacture,
pres
erve
, st
ore,
di
stri
bute
, pr
ocur
e, se
U, o
r di
spen
se,
or b
oth,
any
phar
mace
utic
al
prod
uct
or it
s raw
materials;
or
(b)
Rend
er
serv
ices
, su
ch as
cU
nica
l pharmacy
serv
ices
, drug
info
rmat
ion
serv
ices
, regulatory
serv
ices
, ph
arma
ceut
ical
ma
rket
ing,
me
dica
tion
ma
nage
ment
, or
wh
enev
er the
expe
rtis
e and
tecl
inic
al k
nowl
edge
of
the
pharmacist
is r
equi
red;
or
3
(c)
Enga
ge in
teac
hing
sc
ient
ific
, te
chni
cal,
or
pr
ofes
sion
al
pharmacy
courses
in
a sc
hool
or
co
lleg
e of
pharmacy;
or
(d)
Dispense
pharmaceutical
products
in
situations
where
supe
rvis
ion
of di
spen
sing
of
pharmaceutical
prod
ucts
is
req
tdre
d; or
(e)
Chem
ical
, bi
olog
ical
or
mi
crob
iolo
gica
l an
alys
es
and
assa
y of
pharmaceutical
prod
ucts
, fo
od/d
ieta
ry
supp
leme
nts,
he
alth
su
pple
ment
s,
and
cosm
etic
s;
or
(f)
Phys
ico-
chem
ical
an
alys
es fo
r me
dica
l de
vice
s us
ed
in aid
of a
dmin
istr
atio
n of
pha
rmac
euti
cal
prod
ucts
; or
(g)
Admuiistration
of adult
vaccines
as ap
prov
ed
by
the
Food
^and
Drug
Administration
(FDA):
Pro
vid
ed,
That
they
shal
l un
derg
o the
training
on
the
safe
ad
mini
stra
tion
of
adult
vaccines
and
management
of
adverse
event
following
immunization
(AEFI)
for
phar
maci
sts
and
hold
a
cert
ific
ate
of
training
issued
by
an
institution
duly
accr
edit
ed
by
the
Prof
essi
onal
Regulation
Commission
(PRC
): P
rovi
ded
, fa
rth
er,
That
the
safe
administration
of vaccines
be part
of the
higher
educ
atio
n curriculum
for
phar
maci
sts;
or
(h)
Conduct
or
undertake
scie
ntif
ic
research
in
all
aspe
cts
involving pharmaceutical
prod
ucts
and
health
care
; or
(i)
Prov
ideo
ther
serv
ices
wher
epha
rmac
euti
calk
nowl
edge
is
re
quir
ed.
Acti
viti
es under
para
grap
hs
(a),
(b
), (c
),
(d)
and
(i)
are
excl
usiv
e to
hcensed
phar
maci
sts.
Ho
weve
r,
nothing
herein
shal
l be
co
nstr
ued
as
requiring
othe
r pe
rson
s carrying
out
only
the
acti
viti
es under
para
grap
hs
(e),
(f
), (g
) and
Qx)
to
be
lice
nsed
pharmacists,
subj
ect
to
any
qualification
that
is
impo
sed
by ot
her
laws
with
resp
ect
to su
ch p
arti
cula
r ac
tivi
ty.
All
pharmacists
are
expected
to
abid
e by
current
standards
such
as
the
Philippine
Prac
tice
Standards
for
Pharmacists,
Good
Laboratory
Prac
tice
, Good
Distribution
Prac
tice
, Good
Manufacturing
Prac
tice
and
Good
Clinical
Prac
tice
, which
are
deemed
vita
l in
the
perf
orma
nce
of
their
role
s and
func
tion
s in
diff
eren
t pr
acti
ce
area
s.
4
The
Professional
Regulatory
Board
of
Pharmacy,
hereinafter
created,
subject
to
the
approval
of
the
PRC,
as
provided
for
by
Republic
Act
No.
8981,
otherwise
known
as
the
"PRC
Modernization
Act
of 20
00",
and
in
consultation
with
the
integrated
and
accredited
professional
organization
(APO),
may
modify
the
above-enumerated
acts
, se
rvic
es,
or
acti
viti
es,
as the
need
aris
es,
in
orde
r to
conform
to
the
latest
treads
and
developments
in
the
practice
of
the
pharmacy
prof
essi
on:
Pro
vid
ed
, That
such
modifications
are
cons
iste
nt
with
the
enumeration
above.
SEC.
5.
De
fin
itio
n o
f T
erm
s.
- As
used
in
this
Ac
t:
(a)
Ac
cre
dit
ed
pro
fes
sio
na
l o
rga
niz
ati
on
, (A
PO
) refers
to the
duly
integrated
and
accr
edit
ed
professional
organization
of
registered
and
lice
nsed
pharmacists,
of
which
there
shall
be
only
one
(1),
as
pr
escr
ibed
under
Sect
ion
41,
Article
V of
this
Act;
(b)
Ad
ult
vac
cin
es
refer
to ce
rvic
al cancer,
flu
(inf
luen
za),
y pneumococcal,
other
pre-exposure
prophylactic
vaccines
to
' be
administered
to
patients
aged
eighteen
(18)
years
and
above,
and
such
other
vaccines
as may
be
defined
by
the
Department
of
Health
(DOH)
in
an
administrative
issu
ance
;
(c)
Ad
ult
era
ted
/De
teri
ora
ted
ph
arm
ac
eu
tic
al
pro
du
cts
refe
r to
pharmaceutical
prod
ucts
xu
ifit
fo
r human
cons
umpt
ion,
following
the
standards
of
quahty
or
purity
of
which,
are
as
those
stated
in
the
Un
ite
d S
tate
s P
ha
rma
co
pe
ia/N
ati
on
al
Fo
rmu
lary
and
Ph
ilip
pin
e P
ha
rma
co
pe
ia i
n its
latest
edition
or
any
standard
refe
renc
e fo
r drugs
and
medi
cine
s which
are
given
official
recognition
as
well
as
those
provided
for
in
RepubKc
Act
No.
3720
, otherwise
known
as
the
"Foo
d,
Drug,
and
Cosmetic
Act",
as
amended,
and
Republic
Act
No.
9711,
known
as the
"Food
and
Drug
Administration
Act
of
2009
";
(d)
Bio
ph
arm
ac
eu
tic
als r
efer
to
pharmaceutical
prod
ucts
that
are
used
for
therapeutic
or
for
in v
ivo
diag
nost
ic
purp
oses
, such
as
vaccines,
sera,
and
drugs
derived
from
li
fe
forms
using
biot
echn
olog
y.
These
include
proteins,
nucl
eic
acids,
or
living
microorganisms
where
the
virulence
is
reduced
and
are
used
for
therapeutic
or for
in v
ivo
diag
nost
ic
purp
oses
;
s
(e)
Br
an
d n
am
e refers
to
the
proprietary
name
given
by
the
manufacturer
to
distinguish
its
product
from
those
of
comp
etit
ors;
(0
Cip
he
r,
Co
de,
or
Sec
ret
Key
refers
to
a method
of
secret
writing
or
use
of
characteristic
style
or
symbol
by
subs
titu
ting
other
lett
er/s
or
ch
arac
ter/
s fo
r the
lett
er/s
intended,
for
the
purpose
of
misleading
the
cons
umer
;
(g)
Co
mp
ou
nd
ing
refe
rs to
the
sum
of p
rocesses
performed
by a
pharmacist
in
drug
preparation
including
the
calculations,
mixing,
assembhng,
packaging,
or labeling
of
a drug:
(i)
as
the
result
of
a prescription
or drug
orde
r by
a physician,
dentist,
or
veteriaarian;
or (i
i) f
or the
purpose
of,
or i
n relation
to,
research,
teaching,
or
chemical
analysis;
(h)
Co
nti
nu
ing
pro
fes
sio
na
l d
ev
elo
pm
en
t (C
PD
) refers
to
the
inculcation
of
advanced
knowledge,
sMlls,
and
ethical
values
in
a post-licensure
specialized
or
in
an
inter-
or
multidisciplinary
field
of
study
for
assimilation
into
professional
prac
tice
, self-directed
research,
and/or
lifelong
learning;
/
(i)
Co
sm
eti
cs
refer.to
a substance
or
preparation
intended
to
be
placed
in
contact
with
the
various
external
parts
of the
human
body
or
with
the
teeth
and
the
mucous
membranes
of
the
oral
cavity,
with
a view
exclusively
or
msdnly
to cleaning
them,
perfuming
them,
changing
their
appearance
and/or
correcting
body
odor,
and/or
protecting
the
body
or
keeping
them
in
good
condition,
as de
fine
d under
Republic
Act
No.
9711;
® C
ou
nte
rfe
it
ph
ar
ma
ce
ut
ica
l pro
du
cts
refer
to
pharmaceutical
products
which
do
not
contain
the
amounts
as claimed;
with
wrong
ingredients;
without
acti
ve
ingredients;
or with
insxifficient
quantity
of
acti
ve ingredients,
which
result
in
the
reduction
of
the
prod
ucts
' sa
fety
, ef
fica
cy,
quality,
strength,
or
purity.
These
also
refer
to
prod
ucts
that
are
deliberately
and
fraudulently
mislabeled
with
respect
to
identity
and/or
source
or
with
fake
packaging,
and
can
apply
to
both
branded
and
gene
ric
prod
ucts
, including
the
following:
6
(1)
The
pharmaceutical
prod
uct
itse
lf or
the
cont
aine
r or
la
beKn
g th
ereo
f or
any
part
of su
ch
prod
uct,
co
ntai
ner,
or
la
behn
g,
bear
ing
without
authorization;
the
trademark,
trad
e na
me,
or ot
her
iden
tifi
cati
on m
arks
or imprints
or any
like
ness
to
that
which
is o
wned
or re
gist
ered
in
the
Inte
llec
tual
Pr
oper
ty
Offi
ce (I
PO)
in
the
name
of an
othe
r na
tura
l or
juridical
pers
on;
(2)
A ph
arma
ceut
ical
pr
oduc
t re
fill
ed i
n co
ntai
ners
be
arin
g le
giti
mate
la
bels
or
marks,
without
auth
orit
y;
and
(3)
A ph
arma
ceut
ical
pr
oduc
t which
cont
ains
no
amount
of or
a
diff
eren
t ac
tive
in
gred
ient
; or
le
ss than
eigh
ty
perc
ent
(80%
) of
the
acti
ve
ingredient
it
purports
to possess,
as
dist
ingu
ishe
d fi
rom
an
adxi
lter
ated
drug
incl
udin
g re
duct
ion
or lo
ss o
f ef
fica
cy
due
to
expi
rati
on;
(k)
Da
ng
ero
us
dru
gs
refer
to
those
listed
in
the:
(1)
Schedules
annexed
to
the
1961
Single
Convention
on
Narc
otic
Dr
ugs,
as
am
ende
d by
the
1972
Pr
otoc
ol;
(2)
Schedules
'ann
exed
to
the
1971
Single
Convention
on
Psychotropic
Subs
tanc
es;
and
(3)
Annex
of Repubhc
Act
No.
9165
, ot
herw
ise
^kno
wn as
the
"Com
preh
ensi
ve
Dang
erou
s Drugs
Act
of
2002
",
and
its
amen
dmen
ts;
® D
isp
ensi
ng
refe
rs to
the
sum
of processes
perf
orme
d by
a
pharmacist
from
read
ing,
vahdating,
and
interpreting
pres
crip
tion
s;
prep
arin
g; pa
ckag
ing;
la
behn
g;
reco
rd
keep
ing;
do
se c
alcu
lati
ons;
an
d co
imse
hng
or gi
ving
inf
orma
tion
, in
re
lati
on
to t
he s
ale
or t
i'an
sfer
of
phar
mace
utic
al pr
oduc
ts,
with
or
wi
thou
t a
pres
crip
tion
or
me
dica
tion
or
der;
(m)
Dru
gs
refertopharmaceuticalproductsthatpe.rtain
to ch
emic
al compounds
or b
iolo
gica
l su
bsta
nces
, ot
her
than
food
, intended
for
use
ui
the
treatment,
prev
enti
on,
or di
agno
sis
of
dise
ase
in
hiimans
or an
imal
s, i
nclu
ding
th
e fo
llow
ing:
(1)
Any
article
recognized
in
the
official
Un
ite
d S
tate
s P
ha
rma
co
pe
ia/N
ati
on
al F
orm
ula
ry,
Ho
me
op
ath
ic
Ph
arm
ac
op
eia
of
th
e U
nit
ed
Sta
tes
of
Am
eri
ca
, P
hil
ipp
ine
Ph
arm
ac
op
eia
, P
hil
ipp
ine
Na
tio
na
l D
ru
g F
orm
ula
ry,
Bri
tis
h P
ha
rma
co
po
eia
, E
ur
op
ea
n P
ha
rma
co
po
eia
, J
ap
an
es
e P
ha
rma
co
po
eia
, and
any
official
compendium
or any
supp
leme
nt
to
them;
(2)
Any
article
intended
for
use
in
diag
nosi
s,
cure
, mi
tiga
tion
, tr
eatm
ent,
or
prev
enti
on o
f di
seas
e of
manor
anim
als;
(3)
Any
arti
cle,
other
than
food
, intended
to
affe
ct
the
stru
ctur
e or
any
function
of th
e human
body
or
animals;
(4)
Any
arti
cle
inte
nded
fo
r us
e, as
a
comp
onen
t of
ar
ticl
es,
spec
ifie
d in
clau
ses
(1),
(2
) and
(3),
not
inc
ludi
ng de
vice
s or
their
comp
onen
ts,
part
s and
acce
ssor
ies;
an
d
(5)
Herbal
or tr
adit
iona
l dr
ugs
as de
fine
d in
Repubhc
Act
No.
9502
;
(n)
Em
erg
ency
ca
ses
refe
r to
Hf
e-th
reat
enin
g si
tuat
ions
wh
ere
apat
ient
nee
ds i
mmed
iate
me
dica
l at
tent
ion
and
trea
tmen
t,
incl
udin
g the
occurrence
of ep
idem
ic
or na
tura
l ca
lami
ties
;
(o)
Ex
pir
ati
on
da
te
refe
rs
to
the
end
date
when
the
manufacturer
can
guarantee
that
a pr
oduc
t possesses
its
clai
med
pote
ncy,
ef
fica
cy,
quah
ty,
and
safe
ty;
afte
r which
its
sale
or
di
stri
buti
on i
s pr
ohib
ited
;
(p)
Fill
ing
.ref
ers
to
the
act
of di
spen
sing
or
providing
medi
cine
s in ac
cx^d
ance
with
a pr
escr
ipti
on or
me
dica
tion
or
der;
(q)
Fo
od
/Die
tary
su
pp
lem
ents
refe
r to
processed
food
prod
ucts
in
tend
ed to
su
pple
ment
the
diet
that
bear
s or
co
ntai
ns
one
(I)
or more
of the
foll
owin
g di
etar
y in
gred
ient
s: vitamins,
mine
rals
, he
rbs,
or
other
bota
nica
ls,
amin
o ac
ids,
and
dietary
substances
to
incr
ease
the
tota
l daily
intake
in
amounts
conf
ormi
ng
to the
late
st Ph
ilip
pine
-rec
omme
nded
en
ergy
and
nutrient
intakes
or
internationally
agreed
minimum
daily
requ
irem
ents
. It
usu
ally
is
in t
he f
orm
of c
apsu
les,
tab
lets
, hq
uids
, ge
ls,
powd
ers,
or
piH
s and
not
repr
esen
ted
for
use
as a
conv
enti
onal
food
or as
the
sole
item
of a
meal
or di
et o
r re
plac
emen
t of
dr
ugs
and
medi
cine
s,
as de
fine
d un
der
Repubhc
Act
No.
9711
;
(r)
Ge
ne
ric
na
me
refers
to
the
scientifically
and
inte
rnat
iona
lly
recognized
name
of th
e ac
tive
in
gred
ient
s,
as
appr
oved
by
th
e FD
Apiu
rsua
nt t
o Repubhc
Act
No.
6675
, ot
herw
ise
known
as the
"Gen
eric
s Act
of
1988
";
8
(s)
He
alt
h s
up
ple
me
nt
refe
rs
to
any
product
that
is
used
to
main
tain
, en
hanc
e and
improve
the
healthy
function
of
the
human
body
afid
con
tain
s on
e (1
) or
more
or a
combination
of
the
foll
owin
g: (
1) h
erba
l fa
tty
acid
s, en
zyme
s, pr
obio
tics
, and
othe
r bi
oact
ive
subs
tanc
es;
and
(2)
subs
tanc
es
deri
ved
firo
m na
tura
l so
urce
s, in
clud
ing
anim
al,
plan
t, m
iner
al,
and
bota
nica
l ma
teri
als
in
the
form
of
extr
acts
, is
olat
es,
conc
entr
ates
, me
tabo
Utes
, sy
nthe
tic
sources
of su
bsta
nces
mentioned
in
(1)
and
(2).
It
is
pres
ente
d in do
sage
for
ms or
in
small
xmit d
oses
suc
h as
ca
psul
es,
tabl
ets,
po
wder
, hquids
and
it
shall
not
incl
ude
any
ster
ile
prep
arat
ions
(i
.e.
inje
ctib
les,
ey
edro
ps);
'(t)
'-H
ouse
hold
rem
/3(Ue
s re
fer
to a
ny
prep
arat
ion
cont
aini
ng
phar
mace
utic
al su
bsta
nces
of
co
mmon
or
ordinary
use
to re
liev
e common
phys
ical
ai
hnen
ts and
which
may
be di
spen
sed
without
a me
dica
l pr
escr
ipti
on i
n or
igma
l pa
ckag
es,
bott
les
or co
ntai
ners
, of
which
the
nomenclature
has
been
duly
appr
oved
by
the
FDA;
(u)
Inst
itu
tio
nal
p
ha
rma
cie
s refer
to
pharmacies
of
inst
itut
ions
, or
gani
zati
ons,
and
/or
coip
orat
ions
th
at p
rovi
de a
rang
e of
pharmaceutical
serv
ices
, gi
ven
excl
usiv
ely
to the
empl
oyee
s ^n
d/or
their
quaU
fLed
de
pend
ents
;
(v)
Inte
rns
hip
pro
gra
m re
fers
to
a
supe
rvis
ed
prac
tica
l ex
peri
ence
that
is required
to
be
comp
lete
d fo
r hc
ensu
re
as
a re
gist
ered
ph
arma
cist
;
(w)
Lab
el re
fers
to
a d
ispl
ay of
wri
tten
, pr
inte
d, o
r gr
aphi
c matter
on
the
immediate
cont
aine
r of
any
arti
cle;
(x)
Lab
elin
g ma
terial
s re
fer
to a
H la
bels
and
othe
r wr
itte
n,
printed,
or
grap
hic
matter:
(1)
upon
any
item
or
any
of
its
cont
aine
rs or
wr
appe
rs;
or
(2)
acco
mpan
ying
any
such
item;
(y)
Me
dic
al
devi
ce
refe
rs to
any
inst
rume
nt,
appa
ratu
s,
implement,
mach
ine,
ap
phan
ce,
implant,
in
vitr
o reagent
or
cahb
rato
r, so
ftwa
re,
mate
rial
or
ot
her
similar
or related
arti
cle
inte
nded
by
the
manu
fact
urer
to
be us
ed al
one,
or
in
comb
inat
ion,
fo
r human
bein
gs,
for
one
(1)
or more
of the
spec
ific
pu
rpos
es
of:
diag
nosi
s, prevention,
monitoring,
treatment,
or
alle
viat
ion
of di
seas
e;
diag
nosi
s,
monitoring,
treatment,
or al
levi
atio
n of
or
compensation
for
an
injury;
investigation,
replacement,
modi
fica
tion
or
sup
port
of
the
anatomy
of a
phy
siol
ogic
al pr
oces
s;
9
supporting
or
sustaining
hfe;
preventing
infection;
control
of co
ncep
tion
; di
sinf
ecti
on.o
f me
dica
l de
vice
s; and
providing
information
for
medical
or
diag
nost
ic
purp
oses
by
me
sms
of
in v
itro
examination
of s
peci
mens
de
rive
d fr
om th
e human
body.
This
device
does
not
achi
eve
its
primary
intended
acti
on in
or
on
the
human
body
by
phar
maco
logi
cal,
immunological,
or
meta
bohc
me
ans,
but
which
may
be
assi
sted
in
its
intended
func
tion
by
su
ch me
ans,
as
de
fine
d un
der
Repu
bhc
Act
No.
9711;
(z)
Me
dic
al
mis
sio
n re
fers
to
an
activity
cond
ucte
d on
normal
circ
umst
ance
s of
an
individual
or
a gr
oup
of
health
care
pr
acti
tion
ers
to p
rovi
de health
serv
ices
ou
tsid
e the
hosp
ital
, cU
nic,
and
health
care
facility
premises
as
differentiated
from
humanitarian
missions
and
relief
oper
atio
ns
which
is
cond
ucte
d during
emer
genc
y situations
such
as
ca
lami
ty,
war,
or na
tura
l and
man-made
disa
ster
s;
(aa)
M
ed
icin
es
refe
r to
dru
gs in
th
eir
appr
opri
ate
dosage
form
s, with
assu
red
quality,
safe
ty and
effi
cacy
fo
r humans
or
anim
als,
or
both;
(bb)
M
ed
ica
l re
pre
se
nta
tiv
e or
p
rofe
ss
ion
al
serv
ice
repr
esen
tati
ve
refe
rs to
on
e who
repr
esen
ts any
duly
authorized
manufacturer,/^distributor,
trader,
and
wholesaler
of
pharmaceutical
prod
ucts
and
whos
e primary
duty
is t
o promote
thei
r pr
oduc
ts to
duly
hcensed
health
prof
essi
onal
s;
(cc)
N
on
tra
dit
ion
cd
outl
ets
refe
r to
entities
hcensed
by
appr
opri
ate
government
agencies
to
disp
ense
ov
er-t
he-c
ount
er
medi
cine
s based
on
an
appr
oved
hs
t;
(dd)
O
nli
ne
ph
arm
ac
y se
rvic
es
refe
r to
pharmaceutical
serv
ices
of
a
duly
lice
nsed
ph
arma
ceut
ical
outlet
done
over
the
inte
rnet
;
(ee)
O
ver-
the-
cou
nte
r (O
TC
) m
edic
ines
refe
r to
me
dici
nes
used
fo
r symptomatic
rehef
of m
inor
ailm
ents
and
which
may
be
disp
ense
d without
a pr
escr
ipti
on;
(S)
Ph
arm
ac
eu
tic
al e
sta
bli
sh
me
nts
refer
to
entities
hcensed
by
appr
opri
ate
government
agen
cies
, and
which
are
invo
lved
in
the
manu
fact
ure,
imp
orta
tion
, ex
port
atio
n, re
pack
ing,
and
dist
ribu
tion
of
pharmaceutical
prod
ucts
to
pharmaceutical
outl
ets;
(gg)
Ph
armac
eutic
al ma
nufac
turers
re
fer
to es
tabl
ishm
ents
engaged
in
any
or all
oper
atio
ns
involved
in
the
production
of
phar
mace
utic
al pr
oduc
ts in
clud
ing
the
prep
arat
ion,
pr
oces
sing
, co
mpou
ndin
g,
formulating,
fill
ing,
pa
ckag
ing,
re
pack
agin
g,
alte
ring
, ornamenting,
finishing
and
labe
hng,
preparatory
to
thei
r st
orag
e, sa
le,
or di
stri
buti
on,
except
the
comp
ound
ing
and
filU
ng of
pre
scri
ptio
ns
in p
harm
aceu
tica
l ou
tlet
s;
(!aii)
Ph
arm
ac
eu
tic
al
ma
rke
tin
g refers
to
any
activity
undertaken,
orga
nize
d,
or
spon
sore
d by
a
pharmaceutical
esta
bhsh
ment
or
out
let
which
is d
irec
ted
at p
romoting
its
prod
uct;
(ii)
P
ha
rma
ce
uti
ca
l ou
tlet
s re
fer
to entities
hcensed
by
appr
opri
ate
government
agen
cies
, and
which
are
involved
in
comp
ound
ing
and/
or di
spen
smg
and
seUi
ng of
pharmaceutical
prod
ucts
di
rect
ly t
o pa
tien
ts o
r en
d-us
ers;
(ij)
P
har
mac
euti
cal
pro
du
cts
refe
r to
dr
ugs,
me
dici
nes,
bi
olog
ical
s,
pharmaceutical
and
biop
harm
aceu
tica
l pr
oduc
ts/
spec
ialt
ies,
veterinary
prod
ucts
, veterinary
biol
ogie
s and
vete
rina
ry me
dici
nal
prod
ucts
;
\) P
ha
rma
cis
t re
fers
to
a
health
prof
essi
onal
who
has
been
re
gist
ered
and
issu
ed
a vahd
Cert
ific
ate
of
Registration
(COR)
and
Prof
essi
onal
Identiacation
Card
(PIC)
by the
PRC
and
the
Prof
essi
onal
Regulatory
Board
of
Pharmacy;
(Jl)
P
ha
rma
cis
t-o
nly
OT
C m
edic
ines
refe
r to
ov
er-t
he-
coun
ter
medi
cine
s cl
assi
fied
by
ap
prop
riat
e go
vern
ment
ag
enci
es
to be
ob
tain
ed on
ly f
rom
a hcensed
phar
maci
st,
with
mandatory
phar
maci
st's
ad
vice
on
thei
r se
lect
ion
and
prop
er
use;
(mm)
Ph
arm
ac
y ai
des
refe
r to
pers
ons
who
assi
st
the
phar
maci
sts
in
the
diff
eren
t as
pect
s of
pha
rmac
y op
erat
ion
based
ones
tabh
shed
st
anda
rd o
pera
ting
pro
cedu
res
and
proc
esse
s,
with
very
minimal
degree
of in
depe
nden
ce
or de
cisi
on
making
and
without
dire
ct in
tera
ctio
n wi
th pa
tien
ts;
(nn)
P
ha
rma
cy
assi
stan
ts
refe
r to
per
sons
who
assi
st the
phar
maci
sts
in
diff
eren
t as
pect
s of
pha
rmac
y op
erat
ion
based
on
esta
bhsh
ed
stan
dard
op
erat
ing
proc
edur
es
and
proc
esse
s, w
ith
a minimum
degree
of in
depe
nden
ce
or de
cisi
on
making
and
may
have
supe
rvis
ed in
tera
ctio
n wi
th pa
tien
ts;
11
(oo)
P
ha
rma
cy
tech
nic
ian
s re
fer
to p
erso
ns who
assi
st
in
comp
ound
ing
and
disp
ensi
ng of
med
icin
es in
comm
unit
y, ho
spit
al,
institutional
and
industrial
settings
or
engaged
in
other
activities
under
the
supervision
of
the
pharmacist
as
desc
ribe
d in
Sect
ion
39,
Article
IV
of t
his
Act;
(pp)
P
hil
ipp
ine
Pra
ctic
e S
tan
dar
ds
for
Ph
arm
acis
ts
refe
r to
the
esta
blis
hed
national
firamework
for
quahty
standards
and
guid
elin
es
of the
prac
tice
of
pharmacy
that
resp
ond
to
the
needs
of the
people
who
require
the
phar
maci
sts'
se
rvic
es
to
provide
optimal,
evidence-based
care
as
formulated
by
the
integrated
APO
and
approved
by
the
Professional
Regulatory
Board
of
Pharmacy;
(qq)
P
hysi
cian
's s
amp
les
refe
r to
med
icin
es gi
ven
to he
alth
pr
ofes
sion
als
for
promotional
purp
oses
on
ly;
i
(rr)
P
res
cri
pti
on
/Eth
ica
l med
icin
es
refe
r to
medi
cine
s which
can
only
be di
spen
sed
by a
pharmacist
to a
patient,
upon
the
pres
enta
tion
of
a vahd
pres
crip
tion
from
a ph
ysic
ian,
de
ntis
t,
or v
eter
inar
ian
and
for
which
a ph
arma
cist
's ad
vice
is
ne
cess
ary;
(ss)
R
efi
llin
g o
f a,
pre
sc
rip
tio
n refers
to
the
act
of
dispensing
the
remaining
bala
nce
of
medi
cine
s ordered
in
the
pres
crip
tion
; /
(tt)
R
efe
rra
l re
fers
to
the
process
wherein
a pharmacist
provides
consultative
serv
ices
and
conducts
preliminary
asse
ssme
nt
of symptoms
and
refe
rs the
patient
to a
physician
or
othe
r health
care
pr
ofes
sion
al;
(uu)
Re
ferral
reg
istry
refe
rs to
the
rec
ord
book
maintained
by pharmacists,
list
ing
the
pati
ents
referred
to
diff
eren
t health
faci
htle
s fo
r fu
rthe
r di
agno
sis;
(w)
Re
fre
sh
er
pro
gra
m refers
to
a pr
escr
ibed
study
program
in
an
accr
edit
ed
scho
ol of
pharmacy;
and
(ww)
T
ele
ph
arm
ac
y se
rvic
es
refer
to
pharmaceutical
serv
ices
of
a
duly
hcensed
pharmaceutical
outlet
done
through
the
use
of
tele
phon
e,
tele
conf
eren
cing
, or
fa
csim
ile.
12
ARTICLE
II
TH
E PROFESSIONAL
REGULATORY
BOARD
OF
PHARMACY
SEC.
6.
Cre
atio
n of
th
e P
rofe
ssio
nal
R
eg
ula
tory
B
oa
rd
of P
har
mac
y.
- Th
ere
is h
ereb
y cr
eate
d a
Prof
essi
onal
Re
gula
tory
Board
of
Pharmacy,
hereinafter
call
ed
the
Board,
under
the
administrative
control
and
supervision
of
the
PRC,
to
be
composed
of
a Chairperson
and
two
(2)
members,
to
be
appo
inte
d by
the
President
of the
Philippines
from
a hst
of
three'
(a)
recommendees
for
each
position
ranked
in
the
orde
r of
pref
eren
ce
and
submitted
by
the
PRC
from
a hst
of
five
(5
) nominees
submitted
for
each
position
by
the
duly
inte
grat
ed APO
of ph
arma
cist
s.
SEC.
7.
Qu
alif
icat
ion
s of
the
C
hai
rper
son
an
d M
em
be
rs
of t
he
Bo
ard
. -
The
Chairperson
and
members
of t
he Bo
ard,
at
the
time
of no
mina
tion
, must:
\)
Be
a ci
tize
n of
the
Phihppines
and
a re
side
nt fo
r at
leas
t fi
ve (5
) ye
ars;
(b)
Be
a duly
regi
ster
ed
and
lice
nsed
pharmacist
in
the
Phil
ippi
nes,
pre
fera
bly
a ho
lder
of
a m
aste
ral de
gree
in
Phar
macy
, or
it
s eq
uiva
lent
;
(c)
Have
been
in
the
acti
ve pr
acti
ce
of pharmacy
for
the
past
ten
(10)
ye
ars;
(d)
Have
not
been
conv
icte
d of
a
crim
e involving
moral
turp
itud
e;
(e)
Be
a member
in
good
standing
of the
APO
for
at
leas
t fi
ve (5
) ye
ars,
but
not
an
offi
cer
or tr
uste
e th
ereo
f;
and
(0
At
the
time
of a
ppoi
ntme
nt,
must
neit
her
be a
member
of t
he fa
cult
y nor
an
admi
nist
rati
ve of
fice
r of
any
scho
ol,
coll
ege
or university
offe
ring
de
gree
pro
gram
s in
phar
macy
no
r ha
s an
y di
rect
or
in
dire
ct p
ecun
iary
in
tere
st o
r co
nnec
tion
in
any
review
cent
er or
similar
inst
itut
ion.
SEC.
8.
Po
wer
s,
Fu
nct
ion
s,
an
d R
esp
on
sib
ilit
ies
of
the
Bo
ard
. -
The
Board
shall
exercise
the
following
powers,
func
tion
s,
and
resp
onsi
bOit
ies:
13
(a)
Administer
and
implement
the
prov
isio
ns of
th
is Ac
t;
(b)
Promulgate
rules
and
regulations,
administrative
orde
rs,
and
issu
amce
s necessary
to
carr
y out
the
prov
isio
ns
of
this
Ac
t;
(c)
Prepare
hcen
sure
examination
ques
tion
s, sc
ore,
and
rate
the
examinations
and
submit
the
results
thereof
to the
PRC.
The
Board
shall
prep
are,
ad
opt,
is
sue,
or
amend
the
syllabi
or
tabl
es
of
spec
ific
atio
ns
of the
subj
ects
in
the
hcen
sure
examination,
in
consultation
with
the
academe
and
the
Commission
on
Higher
Education
(CHED);
^ (d
) Recommend
the
issu
ance
, su
spen
sion
, re
voca
tion
, or
reinstatement
of the
COR,
PIC
or Sp
ecia
l/Te
mpor
ary
Permits
(STP
) fo
r the
prac
tice
of
pharmacy;
(e)
Administer
oath
s in
accordance
with
the
prov
isio
ns
of
this
Ac
t;
(f)
Regu
la^f
e and
monitor
the
prac
tice
of
pharmacy
in
the
Philippmes;;
including
the
prac
tice
of
subprofessional
serv
ices
su
ch
as pharmacy
tech
nici
ans,
pharmacy
assi
stan
ts,
aide
s, and
othe
r me
dici
ne ha
ndle
rs,
as de
scri
bed
in th
is A
ct;
adop
t me
asur
es
that
may
be
deemed
prop
er
for
the
enhancement
of the
prof
essi
on
and
the
maintenance
of high
prof
essi
onal
, academic,
ethical,
and
technical
standards;
and
conduct
ocular
inspection
of
pharmaceutical
establishments
and
higher
education
institutions
(HEI
s),
in
coordination
with
concerned
gove
rnme
nt ag
enci
es;
(g)
Promulgate
and
pres
crib
e the
Pharmacists'
Code
of
Ethics,
Code
of
Technical
Standards
and
Guidelines
for
the
Professional
Practice
of
the
Pharmacy
Profession,
in
coor
dina
tion
with
the
APO;
(h)
Represent
the
pharmacy
profession
in
all
fora
involving
concerns
and
issu
es
related
to
pharmaceutical
prod
ucts
and
the
prac
tice
of
pharmacy;
(i)
Investigate
cases
arising
from
violations
of
this
Ac
t, the
rules
and
regu
lati
ons
promulgated
pursuant
ther
eto,
th
e Pharmacists'
Code
of Et
hics
, Code
of Te
chni
cal
Standards
14
and
Guid
elin
es
for
the
Prof
essi
onal
Pr
acti
ce
of the
Pharmacy
Prof
essi
on,
and
othe
r Board
issu
ance
s; is
sue
sxmi
mons
, su
bp
oen
a a
d te
sti
fic
an
du
m and
sub
po
ena
du
ces
tec
um
to
secure
the
atte
ndan
ce of
wit
ness
es or
pro
duct
ion
of d
ocum
ents
, or
bot
h,
and
othe
r evidence
necessary
for
such
investigation
or hearing;
and
rend
er de
cisi
on thereon
which
shah
, im
less
ap
peal
ed t
o the
PRC,
become
fina
l and
exec
utor
y af
ter
fift
een
(15)
days
from
rece
ipt
of no
tice
of
judgment
or
deci
sion
;
Q)
Dele
gate
th
e he
arin
g or
inv
esti
gati
on o
f ad
mini
stra
tive
ca
ses-
file
d before
the
Board,
except
where
the
issue
or
question
involves
the
prac
tice
of
the
prof
essi
on,
in
which
case
, the
hearing
shall
be
pres
ided
ov
er
by
at
leas
t on
e (1
) member
of the
Board,
to be
as
sist
ed
by
a Legal
or
Hearing
Offi
cer
of
the
PRC;
(k)
Cond
uct,
through
the
Legal
Offi
cers
of
the
PRC,
summary
proceedings
on
minor
violations
of
this
Act,
the
General
Instruction
to
the
Examinees,
including
the
implementing
rules
and
regulations
issu
ed
by
the
Board,
and
to
render
summary
judgment
thereon
which
shal
l,
unle
ss
appealed
to
the
PRC,
become
fina
l and
executory
after
fift
een
(15)
days
from
rece
ipt
of n
otic
e of
judgment
or
deci
sion
;
0)
Issue
and
promulgate
guidelines
on
CPD,
in
coor
dina
tion
with
the
APO;
(m)
Recommend
the
accr
edit
atio
n of
the
stan
dard
ized
training
programs
for
and
certifications
of
medical
repr
esen
tati
ves
or p
rofe
ssio
nal
serv
ice
repr
esen
tati
ves,
ph
arma
cy
technicians,
pharmacy
assistants,
pharmacy
aides
and
other
medi
cine
handlers
covered
in
Sect
ion
39,
Article
IV
of
this
Act.
The
Board
shall
promulgate
the
criteria
and
guidehnes
in
the
accreditation
of
training
programs
and
cert
ific
atio
ns as
described
abov
e, in
coor
chna
tion
with
the
APO
and
with
other
concerned
gove
rnme
nt ag
enci
es;
(n)
Accredit
Spec
ialt
y Boards
of
Pharmacy
based
on
the
criteria
that
it
shaU
es
tabh
sh
and
pres
crib
e;
and
(o)
Perform
and
disc
harg
e su
ch
other
functions
and
resp
onsi
bili
ties
, as
may
be
deemed
imphed,
inci
dent
al,
and
necessary,
to pr
eser
ve
the
integrity
of the
pharmacy
hcen
sure
16
examination
and
to
enha
nce
and
upgr
ade
the
prac
tice
of
the
pharmacy
prof
essi
on in
the
coun
try.
SEC.
9.
Te
rm
of
Offic
e of
the
Me
mb
ers
of
the
Bo
ard
. -
The
Chairperson
and
members
of the
Board
shaU
hold
offi
ce
for
a term
of three
(3)
year
s from
the
date
of
appointment
or
untU
. th
eir
successors
shall
have
been
qual
ifie
d and
appo
inte
d.
They
may
be
reap
poin
ted
in
the
same
of
fice
fo
r an
othe
r term
of three
(3)
year
s immediately
afte
r the
expiry
of th
eir
term:
Pro
vid
ed,
That
no
member
of
the
Board
shall
hold
of&c
e fo
r more
than
two
(2)
terms
or n
ot
more
than
sis
(6)
year
s:
Pro
vid
ed,
furt
he
r.
That
the
firs
t Board
appointed
under
this
Act
shah
hold
the
se terms
of o
ffic
e: th
e Ch
airp
erso
n fo
r th
ree
(3)
year
s,
the
firs
t member
for
two
(2)
year
s, an
ci the
second
member
for
one
(1)
year
: P
rovi
ded
, fi
nall
y. That
an
appo
inte
e to
a
vacancy
shah
serv
e only
the
unexpired
portion
of t
he term
of o
ffic
e.
The
Chairperson
and
members
of
the
Board
shah
duly
take
thei
r oath
of o
ffic
e be
fore
a
duly
auth
oriz
ed
offi
cer.
SEC.
10.
Co
mp
en
sa
tio
n a
nd
All
ow
an
ce
s of
the
B
oa
rd.
-The
Chairperson
and
members
of
the
Board
shall
rece
ive
comp
ensa
tion
aiid
aUow
ance
s co
mpar
able
to
the
comp
ensa
tion
and
allo
wanc
es
rece
ived
by
the
members
of the
othe
r existing
prof
essi
onal
re
gula
tory
boards
under
the
PRC,
as pr
ovid
ed fo
r in
the
General
Appr
opri
atio
ns Ac
t.
SEC.
11.
Gro
un
ds
for
Su
spen
sio
n or
R
em
ov
al
fro
m Of
fice
of t
he C
hairp
et'so
n or
M
em
be
r of
the
Bo
ard
. -
The
President
of
the
Phih
ppin
es may,
upon
reco
mmen
dati
on
of t
he PRC
and
afte
r du
e pr
oces
s, s
uspe
nd or
re
move
the
Chairperson
or any
member
of t
he Board
on
any
of t
he fohowing
groi
mds:
(a)
Gros
s ne
glec
t,
inco
mpet
ence
, or
di
shon
esty
in
the
disc
harg
e of
du
ty;
(b)
Involvement
in
the
manipulation,
tampering,
or
rigging
of the
hcen
sure
examination,
its
ques
tion
s or
re
sult
s,
or
both,
and
in
the
clis
clos
ure
of
clas
sifi
ed
and
conf
iden
tial
in
form
atio
n pertaining to
the
hcen
sure
examination;
(c)
Conv
icti
on of
an
offe
nse
involving
moral
turpitude
by
a co
urt
of c
ompe
tent
ju
risd
icti
on;
and
16
(d)
Unpr
ofes
sion
al,
vmet
hica
l, i
mmoral,
or
dish
onor
able
co
nduc
t.
The
PRC,
in
the
conduct
of i
nves
tiga
tion
, shaU
be
guid
ed
by Se
ctio
ns 7
and
15 of
Repubhc
Act
No.
8981,
the
exis
ting
rules
on
admimstrative
inve
stig
atio
n, a
nd
the
Rule
s of
Co
urt.
SEC.
12.
Cu
sto
dia
n o
f it
s R
ec
ord
s,
Se
cre
tari
at
an
d S
up
po
rt
Ser
vice
s.
- AU
records
of th
e Board,
pertaining
to the
applications
for
examinations,
administrative
and
other
inve
stig
ativ
e he
arin
gs conducted
by the
Boar
d, sh
aU be
under
the
cust
ody
of the
PRC.
The
PRC
shall
desi
gnat
e a
Secr
etar
y who
shallprovide
the
Board
with
se
cret
aria
t and
othe
r su
ppor
t se
rvic
es to
implement
the
prov
isio
ns of
tli
is Ac
t.
ARTICLE
III
EXAMINATION,
REGISTRATION,
AND
LICENSURE
\. 13
. L
icen
sure
Ex
am
ina
tio
n R
eq
uir
em
en
t. —
Unless
exempted
therefrom,
ah
apph
cant
s fo
r registration
for
the
prac
tice
of
pharmacy
shall
be
required
to
pass
a hcensure
examination,
as
prov
ided
fo
r in
this
Act
and
Sect
ion
7(d)
of
Repubhc
Act
No.
8981.
SEC.
14.
Qua
lifi
cati
ons
for
the
Lic
ensu
re E
xam
inat
ion
. -
An
apph
cant
fo
r the
Phar
maci
sts'
Li
cens
ure
Examination
shall
esta
blis
h to
the
sati
sfac
tion
of
the
Board
that
the
following
qual
ific
atio
ns ar
e met:
(a)
A ci
tize
n of
the
Phihppines
or of
a
fore
ign
country
which
has
a law
or pohcy
on
reci
proc
ity
for
the
prac
tice
of
th
e pharmacy
prof
essi
on;
(b)
Of
good
moral
char
acte
r and
repu
tati
on;
(c)
A de
gree
ho
lder
of
Ba
chel
or
of Sc
ienc
e in
Pharmacy
or it
s eq
uiva
lent
de
gree
co
nfer
red
by an
HEI
in
the
Phil
ippi
nes
or an
inst
itut
ion
of le
arni
ng in
a fo
reig
n co
untr
y du
ly re
cogn
ized
bythe
CHED;
and
(d)
Has
comp
lete
d an
inte
rnsh
ip program
appr
oved
by
th
e Board,
pursuant
to
such
gu
idel
ines
as
may
hereinafter
be
17
prom
ulga
ted,
in
cons
ulta
tion
wit
h th
e du
ly r
ecog
nize
d as
soci
atio
ns
of p
harmacy
scho
ols
and
the
CHED.
SEC.
15.
Scope
of
Ex
am
ina
tio
n.
~ The
Pharmacists'
Lice
nsur
e Examination
shaU
cover
the
fohowing
subj
ects
on
Pharmacy
Science
and
Prac
tice
: Inorganic
Pharmaceutical
Chem
istr
y, Or
gani
c Ph
arma
ceut
ical
Ch
emis
try,
Qua
htat
ive
and
Quan
tita
tive
Pharmaceutical
Chemistry,
Phar
maco
gnos
y and
Plan
t Chemistry,
Phar
mace
utic
al
Bioc
hemi
stry
, Mi
crob
iolo
gy
and
Parasitology,
Physical
Pharmacy,
Biopharmaceutics,
Pharmacology
and
Toxicology,
Manufacturing,
Quality
Assu
ranc
e and
Inst
rume
ntat
ion,
Ph
arma
ceut
ical
Ca
lcul
atio
ns,
Drug
Dehvery
Syst
ems,
Ho
spit
al P
harm
acy,
Ch
nica
l Pharmacy,
Dispensing
and
Medication
Counseling,
Pharmaceutical
Admi
nist
rati
on a
nd M
anag
emen
t, Pu
bhc
Heal
th,
Lega
l Ph
arma
cy,
and
Ethi
cs.
The
Board,
subj
ect
to
the
approval
of
the
PRC,
may
intr
oduc
e relevant
changes
on
the
subj
ect
area
s, format,
and
cont
ent
of the
examination,
as well
as on
the
relative
weight
attr
ibut
ed t
o each
examination
subj
ect,
as
the
need
aris
es,
and
in
cons
ulta
tion
wi1
^ the
duly
recognized
asso
ciat
ions
of
pharmacy
scho
ols
and
the
CHED.
SEC.
16.
Ho
ldin
g o
f E
mm
ina
tio
n.
- The
Pharmacists'
Lice
nsur
e Examination
shah
be
given
two
(2)
times
a year
in
places
and
date
s as
the
PRC
may
desi
gnat
e in
the
Resolution
providing
for
the
master
schedule
of a
h hc
ensu
re
examinations
pursuant
to S
ecti
on 7(
d) of
Repubhc
Act
No.
8981.
SEC.
17.
Ra
tin
gs
in the
L
icen
sure
Exa
min
atio
n.
- In
or
der
to
be
regi
ster
ed
and
hcensed
as
a pharmacist,
a ca
ndid
ate
must
obtain
a general
weighted
average
of
seventy-five
perc
ent
(75%
),
with
no
rating
lower
than
fifty
perc
ent
(50%
) in
an
y of
the
subj
ects
.
An
apph
cant
who
failed
in
the
hcen
sure
examination
for
the
thir
d (^^^)
time
shal
l no
t be
al
lowe
d to
tak
e th
e ne
xt su
ccee
ding
examinations
without
having
undertaken
a re
fres
her
program
in a
duly
accr
edit
ed
inst
itut
ion.
The
Board
shah
issu
e gu
idel
ines
on
the
refr
eshe
r program
requirement.
18
SEC.
18.
Rep
ort
of
Rat
ing
. -
The
Board
shah
submit
to
the
PRC
the
ratings
obta
ined
by
ea
ch ca
ndid
ate
with
in three
(3)
working
days
after
the
last
day
of the
examination,
unle
ss
exte
nded
fo
r Ju
st ca
use.
Upon
the
rele
ase
of the
results
of the
exam
inat
ion,
the
PRC
shah
send
by
the
rati
ng ob
tain
ed by
ea
ch examinee
at
the
given
addr
ess
using
the
niaihng
enve
lope
su
bmit
ted
diur
ing
the
examination.
SEC.
19.
Oa
th o
f P
rofe
ssio
n. -
ALL
succ
essf
id.
cand
idat
es
in the
hcen
sure
examination shaU
take
thei
r oath
of pr
ofes
sion
be
fore
any
member
of t
he Bo
ard,
off
icer
of
the
PRC,
or an
y pe
rson
authorized
by
law
to administer
oath
s, prior
to entering
the
prac
tice
of
the
pharmacy
prof
essi
on.
SEC.
20.
Iss
ua
nc
e o
f C
ert
ific
ate
of
Re
gis
tra
tio
n a
nd
Pro
fess
iona
l Id
enti
fica
tion
C
ard
. -
A COR
as a
pharmacist
shall
be
issued
to
those
who
passed
the
licensure
examination,
subj
ect
to
compliance
with
the
registration
requirements
and
payment
of the
pres
crib
ed
fees
. The
COR
^•sh
ah be
ar
the
registration
number,
the
date
of
its
issu
ance
, and
the
signatures
of
the
Chairperson
of
the
PRC
and
the
members
of the
Board,
stamped
with
the
offi
cial
se
als
of
the
PRC
and
of the
Board,
certifying
that
the
pers
on
named
ther
ein
is entitled
to the
prac
tice
of
the
prof
essi
on,
with
aU
the
priv
ileg
es appurtenant
thereto.
This
COR
shah
remain
in
full
force
and
effect
until
suspended
or
revoked
in
accordance
with
this
Ac
t.
A PIC
bearing
the
registration
number
and
date
s of
its
issu
ance
and
expi
ry,
dxal
y si
gned
by
the
Chairperson
of the
PRC,
shah
hkewise
be is
sued
to
eve
ry re
gist
rant
, upon
payment
of t
he pr
escr
ibed
fe
es.
The
PIC
shaU
be renewed
ever
y th
ree
(3)
year
s, upon
presentation
of
the
Cert
ific
ate
of Good
Standing
(COGS)
from
the
APO
and
proof
of
completion
of the
CPD
requ
irem
ents
.
SEC.
21.
Fo
reig
n R
ecip
roci
ty.
- Unless
the
country
or
stat
e of
which
the
foreign
pharmacist
is a
subj
ect
or ci
tize
n,
spec
ific
aUy
permits
Fhipino
pharmacists
to pr
acti
ce
with
in its
territorial
limits
on
the
same
basis
as
the
subjects
or
citi
zens
of
the
said
foreign
country
or st
ate
under
reci
proc
ity
and
under
inte
rnat
iona
l agreements,
no
fore
igne
r shall
be
19
admitted
to hc
ensu
re
examinations,
given
a COR
to
prac
tice
as
pharmacist
nor
be
entitled
to
any
of the
priv
ileg
es
under
this
Act.
SEC.
22.
Pra
cti
ce
Th
rou
gh
Sp
ec
ial/
Te
mp
ora
ry
Pe
rmit
(ST
P).
- The
prac
tice
of
pharmacy
in
the
Phihppines
shaU
be
hmited
to
natural
persons
only
and
shall
be
governed
by
the
prov
isio
ns
of
Repubhc
Act
No.
8981
and
other
issu
ance
s pertinent
thereto:
Pro
vid
ed
, That
any
foreign
citizen
who
has
gain
ed
entry
in
the
Philippines
to perform
prof
essi
onal
services
within
the
scope
of
the
practice
of
pharmacy,
incl
udin
g the
fohowing:
(a)
bein
g a
consultant
in
fore
ign-
fund
ed
or
assi
sted
pr
ojec
ts
of
the
government;
(b)
bein
g engaged
or
empi
oyed
by
a
Fihpino
employer
or es
tabh
shme
nt;
(c)
providing
free
serv
ices
in
humanitarian
missions;
and
(d)
being
a vi
siti
ng faculty
member
in
any
field
or sp
ecia
lty
in
pharmacy
shall,
before
assuming
such
duties,
functions
and
responsibilities,
secure
an
STP
from
the
Board
and
the
PRC,
under
the
fohowing
cond
itio
ns:
(1)
The
pers
on is
an
inte
rnat
iona
hy renowned
pharmacist
or expert
in
a fi
^ld
or sp
ecia
lty
of
pharmacy;
(2)
The
pers
on is
engaged
in th
e pr
ovis
ion
of a
pr
ofes
sion
al
serv
ice
which
is determined
to b
e ne
cess
ary
due
to l
ack
of Fi
hpin
o sp
ecia
hsto
r ex
pert
; and
(3)
The
person
is
required
to
work
with
a Filipino
coun
terp
art,
a
natu
ral
person
who
is a
regi
ster
ed and
lice
nsed
ph
arma
cist
.
SEC.
23.
Gro
un
ds
for
Non
-reg
istr
atio
n.
- The
Board
shah
not
regi
ster
any
succ
essf
ul
examinee
who
has
been
:
(a)
Conv
icte
d of
an
offe
nse
involving
moral
turpitude
by
a co
urt
of c
ompe
tent
ju
risd
icti
on;
(b)
Summarily
adjudged
by
the
Board
as
guilty
for
misr
epre
sent
atio
n or
fal
sifi
cati
on o
f do
cume
nts
in
conn
ecti
on
with
th
e apphcation
for
examination
or fo
r vi
olat
ion
of the
General
Inst
ruct
ions
to
Examinees;
20
(c)
Found
guil
ty of
immoral
or di
shon
orab
le
conduct
by
the
Boar
d;
(d)
Medi
cahy
pr
oven
to
be
ad
dict
ed
to an
y drug
or
alco
hol
by a
medi
cal
or dr
ug t
esti
ng f
acOi
ty a
ca-e
dite
d by
th
e go
vern
ment
; an
d
(e)
Decl
ared
of
unsound
mind
by
a co
urt
of
comp
eten
t ju
risd
icti
on.
In ^r
efus
ing
the
regi
stra
tion
, th
e Board
shah
give
a
writ
ten
stat
emen
t se
ttin
g fo
rth
the
reas
ons
ther
efor
and
shah
file
a copy
ther
eof
in
its
reco
rds.
Sh
otdd
gr
ound
(d
) be
pr
oven
to
be
no
long
er
exis
tent
, the
Board
shah
issu
e a
Board
Resolution
ahowing
the
issu
ance
of
su
ch
COR.
SEC.
24.
Rei
ssm
nce
of
Rev
oked
Ce
rtific
ate
of
Regis
tratio
n, R
epla
cem
ent
of
Lost
or
D
am
ag
ed
Cer
tifi
cate
of
Reg
istr
atio
n,
Pro
fess
iona
l Id
enti
fica
tion
Ca
rd o
r S
pe
cia
l/T
em
po
rary
P
erm
it.
+ The
Board
may,
upon
peti
tion
, re
inst
ate
or re
issu
e a
revo
ked
COR
afte
r the
expiration
of two
(2)
year
s from
the
date
of
its
revo
cati
on.
The
Boar
d ma
y, in
its
dis
cret
ion,
re
quir
e th
e ap
phca
nt
to t
ake
anot
her
hcen
sure
ex
amin
atio
n. T
he
peti
tion
er s
hah
prov
e to
the
Board
that
ther
e is
a
vahd
reas
on fo
r su
ch
rein
stat
emen
t.
For
the
grant
of the
peti
tion
, th
e Board
shaU
is
sue
a Board
Reso
luti
on,
to b
e ap
prov
ed
by th
e PRC.
A du
phca
te
copy
of the
COR
for
disp
lay
in
Cate
gory
B
esta
bhsh
ment
s may
be is
sued
. Re
plac
emen
t of
los
t or
damaged
COR,
PIC
or STP
may
be is
sued
in accordance
with
the
pert
inen
t ru
les
that
shah
be is
sued
th
ereo
n.
ARTICLE
rv
REGULATION
OF
TH
E PRACTICE
OF
PHARMACY
SEC.
25.
Vest
ed
Rig
hts
; A
uto
ma
tic
Reg
istr
atio
n.
- All
phar
maci
sts
regi
ster
ed
before
the
effe
ctiv
ity
of this
Act
shah
automatically
be re
gist
ered
he
reun
der,
su
bjec
t to
comphance
as
to future
requ
irem
ents
.
21
The
CORs
, PICs
or
STPs
held
by
su
ch
persons
m good
stan
ding
shah
have
the
same
fo
rce
and
effe
ct,
as though
they
were
issu
ed on
or af
ter
the
effe
ctiv
ity
of t
his
Act.
SEC.
26.
Aff
ixin
g R
Ph
Aft
er
a R
egis
tere
d P
ha
rma
cis
t's
Na
me
. -
Only
duly
registered
and
hcensed
pharmacists
shah
have
th
e right
to af
fix
to on
e's
name
, th
e ti
tle
"Reg
iste
red
Phar
maci
st"
or
"RPh".
SEC.
27.
Ind
icat
ion
of I
nfo
rmat
ion
. -
A ph
arma
cist
shah
be
requ
ired
to
in
dica
te
the
seri
al nu
mber
s,
the
date
of
expiry
of the
phar
maci
st's
PIC
and
APO
Cert
ific
ate
of
Membership
on
aU p
ertinent
docu
ment
s si
gned
by
hi
m/he
r.
SEC.
28.
Reg
istr
y of
P
ha
rma
cis
ts.
- The
Board
and
the
PRC
shall
prep
are
and
maintain
a registry
of
the
names,
resi
denc
es or
of
fice
ad
dres
ses,
or
bo
th,
stat
us of
reg
istr
atio
n and
area
of
pr
acti
ce
of aU
regi
ster
ed
phar
maci
sts,
which
shah
be
upda
ted
annuahy,
in
coor
dina
tion
with
the
APO.
This
registry
shah
be
made
av
aila
ble
to the
publ
ic
upon
inquiry
or
requ
est,
su
bjec
t to
su
ch gu
idel
ines
that
shaU
be
esta
bhsh
ed
ther
efor
.
SEC.
29.
Dis
pla
y of
Cer
tifi
cate
of
Reg
istr
atio
n.
- It
shall
be th
e du
ty of
eve
ry ph
arma
cist
engaged
in
the
prac
tice
, v/
heth
er
in pr
ivat
e or
un
der
the
empl
oy
of a
noth
er,
to di
spla
y th
e original
copy
of on
e's
COR
in
a prominent
and
conspicuous
place
in
the
drug
esta
blis
hmen
t in
which
one
is em
ploy
ed
in
a pr
ofes
sion
al
capa
city
as
ph
arma
cist
. When
empl
oyed
in
es
tabh
shme
nts
unde
r Ca
tego
ry
B, as
de
fine
d in
Sect
ion
31
of this
Act,
the
dupl
icat
e copy
of t
he ph
arma
cist
's
COR
shaU
al
so be
di
spla
yed
therein.
No
pharmacist
shall
knowingly
aUow
the
COR
to
be
disp
laye
d in
an
esta
bhsh
ment
where
one
is n
ot a
ctua
lly
empl
oyed
as
a
prof
essi
onal
ph
arma
cist
.
SEC.
30.
Dis
pe
ns
ing
/Sa
le
of
Ph
arm
ac
eu
tic
al
Pro
du
cts.
-
No
phar
mace
utic
al
prod
uct,
of
wh
atev
er
nature
and
kind,
shah
be
compounded,
dispensed,
sold
or
re
sold
, or
ot
herw
ise
be
made
av
aila
ble
to the
consuming
pubhc,
except
through
a re
tail
drug
outl
et d
uly
hcensed
by the
FDA.
Pres
crip
tion
dr
ugs
and
phar
maci
st-o
nly
OTC
medi
cine
s shaU
be
dispensed
only
by
a duly
regi
ster
ed
and
lice
nsed
22
phar
maci
st,
except
in
emergency
case
s, where
the
serv
ices
of
a
regi
ster
ed and
hcensed
pharmacist
are
not
avai
labl
e:
Pro
vid
ed,
That
a re
port
shah
be ma
de to
the
supe
rvis
ing
phar
maci
st
with
in
twen
ty-f
our
(24)
hours
afte
r the
occurrence
of t
he emergency
so
that
pr
oduc
t re
cord
ing
in
the
pres
crip
tion
books
can
be do
ne.
Compounding
and
disp
ensi
ng
shah
be done
only
by
duly
regi
ster
ed and
hcensed
phar
maci
sts,
in accordance
with
current
Good
Manxifacturing
Prac
tice
, la
bora
tory
pr
acti
ce,
Philippine
Prac
tice
Standards
for
Pharmacists
and
disp
ensi
ng
guid
ehne
s.
A re
gist
ered
and
hcensed
pharmacist
may
refu
se to
co
mpou
nd,
dispense
or se
h dr
ugs
and
pharmaceutical
prod
ucts
, if
not
in
accordance
with
th
is A
ct
and
the
abov
emen
tion
ed
stan
dard
s.
Lice
nsed
manufacturers,
importers,
distributors,
and
whol
esal
ers
of p
harm
aceu
tica
l pr
oduc
ts ar
e au
thor
ised
to
seh
thei
r pr
oduc
ts on
ly t
o duly
hcensed
phar
mace
utic
al ou
tlet
s.
SEC.
31.
Ph
arm
ac
ist
Re
qu
ire
me
nt.
- Estabhshments/
outl
ets
which
are
requ
ired
to
empl
oy an
d/or
re
tain
and
main
tain
the
professional
services
of
duly
registered
and
lice
nsed
ph
arma
cist
s shah
be cl
assi
fied
as
fo
hows
:
(a)
Cate
gory
A
- Pharmaceutical
esta
bhsh
ment
s/ou
tlet
s where
the
dire
ct and
immediate
cont
rol
and
supe
rvis
ion
of a
du
ly
regi
ster
ed and
hcen
sed
phar
maci
st i
s re
quir
ed,
per
esta
bhsh
ment
, whether
in-s
tore
or
onhn
e, in
clud
ing:
(1)
Pharmaceutical
establishments/outlets
selling
or
otherwise
making
available
to
the
consuming
public
prescription/ethical
medicines,
combination
products
(med
ical
device
and
drug
s)
clas
sifi
ed
as
drug
s according
to
the
primary
intended
mode
of
acti
on,
pharmacist-only
OTC
medidne,
whether
owne
d by
the
government
or by
a
priv
ate
pers
on or
firm,
whet
her
sold
at
who
lesa
le or
re
tail
;
(2)
Establishments
involved
in
the
manufacture,
impo
rtat
ion,
ex
port
atio
n, d
istr
ibut
ion,
and
sale
of
co
mbin
atio
n pr
oduc
ts (m
edic
al de
vice
and
drug
s) cl
assi
fied
as
dr
ugs
acco
rdin
g to
the
primary
inte
nded
mode
of ac
tion
;
(3)
Departments/Divisions/Units
of
pharmaceutical
labo
rato
ries
, ph
arma
ceut
ical
manufacturing
labo
rato
ries
, or
ot
her
28
estabhshments
with
processes
involving
the
preparation,
manufacture,
assay,
regulation,
product
research
and
deve
lopm
ent,
qu
ahty
con
trol
, re
pack
ing,
im
port
atio
n, ex
port
atio
n,
dist
ribu
tion
, sa
le
or
transfer
of pharmaceutical
prod
ucts
in
quan
titi
es gr
eatl
y in excess
of s
ingl
e th
erap
euti
c do
ses;
and
(4)
Government
unit
s, including
loca
l go
vern
ment
, ci
ty,
firs
t to
th
ird
class
municipal
health
unit
s,
nongovernment
orga
niza
tion
s an
d/or
as
soci
atio
ns
involved
in
the
proc
urem
ent,
di
stri
buti
on,
disp
ensi
ng and
stor
age
of p
harm
aceu
tica
l pr
oduc
ts;
(b)
Cate
gory
B
- Pharmaceutical
esta
bhsh
ment
s/ou
tlet
s where
the
supe
rvis
ion
and
over
sigh
t of
a
duly
regi
ster
ed
and
hcen^d
phar
maci
st is
req
uire
d un
der
pert
inen
t pr
ovis
ions
of
la
w,
incl
udin
g:
(1)
Reta
il
outl
ets
sell
ing
hous
ehol
d re
medi
es
and
OTC
drug
s as
di
ffer
enti
ated
from
the
phar
maci
st-o
nly
OTC
medi
cine
s;
(2)
Sate
Uite
ins
titu
tion
al p
harm
acie
s pr
ovid
ing
medi
cine
s so
lely
to
empl
oyee
s of
the
ir r
espe
ctiv
e co
mpan
ies
or t
he
empl
oyee
s'
qual
ifie
d de
pend
ents
, or
both;
or members
of a
duly
regi
ster
ed
orga
niza
tion
or
in
stit
utio
n;
(3)
Four
th,
fift
h and
sixt
h cl
ass
municipal
health
unit
s in
volv
ed i
n th
e pr
octf
feme
nt,
dist
ribu
tion
, di
spen
sing
, an
d st
orag
e of
pha
rmac
euti
cal
prod
ucts
;
(4)
Inst
itut
ions
providing
tele
phar
macy
se
rvic
es;
and
(5)
Nontraditional
outl
ets
of ph
arma
ceut
ical
pr
oduc
ts:
Pro
vid
ed,
That
no pr
escr
ipti
on me
dici
nes
and
pharmacist-only
OTC
medi
cine
s ar
e so
ld.
The
FDA,
in
coordination
with
the
Board,
and
the
approval
of the
PRC,
may
add
to,
dele
te,
recl
assi
fy,
or
modify
the
above
hst
of es
tabl
ishm
ents
, as
the
need
aris
es,
in
orde
r to
keep
pace
with
the
deve
lopm
ents
in
the
pharmacy
prac
tice
.
A pharmacist
working
in
a Ca
tego
ry A
esta
bhsh
ment
may
be ahowed
to simultaneously
work
or re
nder
pharmacy
serv
ices
in
Ca
tego
ry B
esta
bhsh
ment
s, the
maximmn
number
of h
ours
of
which
shah
be determined,
in
accordance
with
su
ch
guid
elin
es
24
as may
be es
tabl
ishe
d th
eref
or b
y the
Boar
d, in
coor
dina
tion
wi
th
the
FDA,
and
othe
r ag
enci
es,
esta
bhsh
ment
s, in
stit
utio
ns,
and
regu
lato
ry bo
dies
.
Procurement,
stor
age,
di
stri
buti
on,
or di
spen
sing
of
any
pharmaceutical
prod
uct
in
the
national
government
and
loca
l government
units
shaU
be
made
on
ly un
der
the
supe
rvis
ion
of a
did.
y re
gist
ered
and
hcensed
phar
maci
st.
Ah
units
or su
b-un
its
of es
tabh
shme
nts,
in
stit
utio
ns,
and
regu
lato
ry bo
dies
whether
government
or p
riva
te w
ith
func
tion
s and
acti
viti
es t
hat
are
excl
usiv
e fo
r ph
arma
cist
s, as
de
fine
d m
Sect
ion
4, p
arag
raph
s (a
), (b
), (c
), (d
) and
(i),
shahbe
headed
and
mana
ged
by a
quah
fied
du
ly r
egis
tere
d an
d hcensed
phar
maci
st:
Pro
vid
ed,
That
an
appointment
in
government
serv
ice
shall
comp
ly
with
th
e pr
ovis
ions
of
oth
er pertinent
laws.
SEC.
32.
Res
po
nsi
bil
ity
for
Qu
ali
ty o
f P
ha
rma
ce
uti
ca
l P
rod
uct
s.
- It
shah
be th
e duty
of a
duly
hcensed
and
regi
ster
ed
pharmacist
of a
pharmaceutical
estabhshment
and
outlet
to
ensure
that
all
pharmaceutical
products
conform
to
standards
of sa
fety
, quahty
and
effi
cacy
, as
pr
ovid
ed
for
in
this
Act
and
other
pertinent
rules
and
regulations
and
issu
ance
s.
Owners,
managers,
or
pharmacists
in
charge
of
the
operation
of pharmaceutical
estabhshments
and
outl
ets
shaU
be
held
join
tly
resp
onsi
ble
for
nonconformance
with
thes
e st
anda
rds.
It shah
be un
lawf
ul f
or an
y pe
rson
to
man
ufac
ture
, pr
epar
e,
seh,
or
di
spen
se an
y ph
arma
ceut
ical
pr
oduc
t under
a fraudulent
name,
or pr
eten
se or
to
ad
ulte
rate
any
pharmaceutical
prod
uct
offe
red
for
sale
.
In
cases
of p
harm
aceu
tica
l pr
oduc
ts
sold
in
thei
r original
package,
the
seal
of
which
has
not
been
broken
or ta
mper
ed
with
, the
habihty
that
may
aris
e because
of th
eir
quahty
and
puri
ty
rests
upon
the
manufacturer
or
importer,
the
distributor,
repr
esen
tati
ve,
or de
aler
who
is r
espo
nsib
le fo
r th
eir
dist
ribu
tion
or
sa
le.
SEC.
33.
Fill
ing
an
d P
arti
al F
illi
ng o
f Pre
scri
ptio
n.
- Ah
pres
crip
tion
s and
phar
maci
st-o
nly
OTC
medi
cine
s shah
be
fill
ed,
compounded
and
dispensed
only
by
a re
gist
ered
and
hcensed
25
phar
maci
st,
in ac
cord
ance
with
the
Phhi
ppin
e Pr
acti
ce
Stan
dard
s fo
r Pharmacists,
Dispensing
Guid
ehne
s and
othe
r st
anda
rds
pertaining
to
puri
ty,
safety
and
quality.
Completely
fill
ed
prescriptions
should
be
surrendered
to
the
pharmacist
for
reco
rdin
g.
Part
ial
fihi
ng
of pr
escr
ipti
on le
ss than
the
tota
l quantity
indicated
in
the
prescription
shall
be
allowed,
subj
ect
to
disp
ensi
ng gu
ideh
nes
as pr
ovid
ed in
the
immediately
prec
edin
g paragraph.
It
is
the
responsibility
of
the
pharmacist
disp
ensi
ng
the
last
quantity
comp
leti
ng
the
prescription
to
keep
the
prescription
according
to
proper
prescription
reco
rdin
g gu
idel
ines
.
Pres
crip
tion
me
dici
nes
may
be dispensed
only
by a
duly
registered
and
lice
nsed
pharmacist
and
only
with
a valid
pres
crip
tion
of
a p
hysi
cian
, de
ntis
t, o
r ve
teri
nari
an.
SEC.
34.
Ph
ysic
ian
's S
am
ple
. -
Phar
mace
utic
al
prod
ucts
given
or intended
to be
gi
ven
free
to
any
health
prof
essi
onal
by
a
manufacturer
pv
distributor
or
its
professional
serv
ice
repr
esen
tati
ve as
'par
t of
its
program
or promotion
shaU
not
be
sold
to
any
pharmaceutical
outlet
or the
cons
umin
g pubhc.
The
statement
"Sam
ple,
Not
for
Sale
", or
its
equi
vale
nt,
shal
l appear
cons
picu
ousl
y on
the
primary
and
secondary
packaging
of
the
drug
or
combination
products
(medical
device
and
drug
) cl
assi
fied
as
drug
according
to th
e primary
intended
mode
of ac
tion
to
be
gi
ven.
It
shah
be
unlawful
to
remo
ve,
eras
e, de
face
or
mark
the
original
labe
ls of
sa
mple
s.
Pharmaceutical
prod
ucts
cl
assi
fied
as
antimicrobials,
incl
udin
g an
ti-T
B me
dici
nes
and
othe
r cl
assi
fica
tion
s of
me
didn
es,
as may
be pr
escr
ibed
by
the
FDA,
shah
not
be gi
ven
or di
stri
bute
d as
ph
ysic
ian'
s sa
mple
s.
SEC.
35.
Pro
hib
itio
n Ag
ain
st
the
Use
of Ci
pher,
C
odes
, o
r U
nu
su
al
Te
rms
in
Pre
sc
rip
tio
ns
an
d P
res
cri
pti
on
Sub
stit
utio
n.
- Pharmacists
shaU
not
compound
or
dispense
pres
crip
tion
s, re
cipe
s, o
r formulas
which
are
writ
ten
in
ciph
ers,
codes
or se
cret
key
s or
pre
scri
ptio
ns of
pha
rmac
euti
cal
prod
ucts
with
unusual
names
which
diff
er
from
thos
e in
standard
phar
maco
peia
s or
fo
rmul
arie
s.
26
The
phar
maci
st di
spen
sing
or
co
mpoi
mdin
g pr
escr
ipti
ons
shah
not
subs
titu
te th
e me
dici
ne
cahed
for
in
the
pres
crip
tion
wi
th
any
othe
r dr
ug,
subs
tanc
e or
in
gred
ient
, without
prio
r co
nsul
tati
on w
ith,
an
d wr
itte
n co
nsen
t of
the
pe
rson
pr
escr
ibin
g,
except
in
accordance
with
Repubhc
Act
No.
6675
, as
am
ende
d,
othe
rwis
e Imown
as t
he "
Gene
rics
Ac
t of
198
8",
and
othe
r pe
rtin
ent
laws
and
regu
lati
ons.
SEC.
36.
Lab
el
of D
ispe
nsed
M
edic
ines
. -
Upon
ever
y bo
x, bo
ttle
, or
package
of m
edic
ines
compounded
or di
spen
sed
by
a re
gist
ered
an
d hcensed
phar
maci
st based
on pr
escr
ipti
on,
ther
e sh
ahbe
pa
sted
, af
fixe
d, o
r im
prin
ted
a se
al o
r la
bel
bear
ing,
am
ong
othe
rs,
the
name
of pa
tien
t an
d ge
neri
c name
of dr
ug;
brand
name
, if
an
y, st
reng
th,
expi
ry da
te,
dire
ctio
ns fo
r us
e; and
name
and
address
of ph
arma
cy,
name
of the
doct
or,
the
disp
ensi
ng
phar
maci
st and
othe
r re
quir
emen
ts pr
escr
ibed
in
the
Phih
ppin
e Pr
acti
ce St
anda
rds
for
Phar
maci
sts
and
Disp
ensi
ng
Guid
ehne
s,
Repu
blic
Act
No.
9502
, ot
herw
ise
known
as
the
"Universahy
, Accessible
Chea
per
and
Quahty
Medi
cine
s Act
of
2008
",
its
1* '
implementing
rule
s and
regu
lati
ons
and
such
ot
her
guid
elin
es
that
may
be pr
omix
lgat
ed by
th
e Bo
ard.
Auxiliary
labels
containing
special
pharmacists'
inst
ruct
ions
fo
r th
e pa
tien
t shall
be re
quir
ed as
pr
escr
ibed
fo
r da
nger
ous
drug
s,
exte
rnal
-use
-onl
y dr
ugs,
dr
ugs
with
spec
ial
stor
age
and
admi
nist
rati
on i
nstr
ucti
ons
and
such
ot
her
drug
s as
may
be re
quir
ed by
law.
SEC.
37.
Rec
ord
ing
of P
atie
nt
Me
dic
ati
on
Pro
file
. -
Ah
pres
crip
tion
s di
spen
sed
hi
the
phar
macy
sh
aU b
e recorded
in
an
appr
opri
ate
reco
rdin
g sy
stem
in
dica
ting
therein,
among
othe
r th
ings
, the
name
and
addr
ess
of t
he pa
tien
t, n
ame
of
pres
crib
er,
gene
ric
name
and
bran
d, dosage
stre
ngth
, quantity
of drug
and
init
ials
of
ph
arma
cist
. It
shah
be
open
for
insp
ecti
on
by
the
repr
esen
tati
ves
of th
e Board
or th
e FDA,
or bo
th,
at
any
time
of
the
day,
when
the
phar
macy
is
op
en,
and
must
be
kept
fo
r a
peri
od of
not
less
than
two
(2)
year
s af
ter
the
last
entry.
Ah
requ
ired
information
on
dang
erou
s dr
ugs
dispensed
by
a pharmacy
shah
be re
cord
ed i
n th
e Da
nger
ous
Drug
s Bo
ok or
an
equi
vgde
nt re
cord
ing
syst
em as
req
uire
d by
Repubhc
Act
No.
9165
and
other
apphcable
laws
an
d is
suan
ces.
27
AU
refe
rral
s su
ch as
tu
berc
ulos
is pa
tien
ts undertaken
by
the
phar
mace
utic
al
outl
ets
shah
be
recorded
in
the
Referral
Registry
and
shall
be
open
for
insp
ecti
on
by
the
Boar
d,
or
repr
esen
tati
ve of
the
Department
of H
ealth
(DOH)
or the
FDA,
or bo
th,
at
any
time
of the
day
when
the
phar
macy
is
op
en,
and
must
be kept
for
a pe
riod
of
not
less
than
two
(2)
year
s af
ter
the
last
entry.
SEC.
38.
Req
uir
emen
ts f
or
the
Op
en
ing
an
d Op
eratio
n of
R
etai
l P
har
mac
euti
cal
Ou
tlet
or
Est
abli
shm
ent.
-
TTie
op
enin
g of
a r
etai
l ph
arma
ceut
ical
ou
tlet
or
esta
bhsh
ment
sh
ah b
e su
bjec
t to
requirements
prov
ided
fo
r in
this
Act
and
the
rule
s and
regu
lati
ons
pres
crib
ed
by the
FDA.
i. The
apph
cati
on
for
the
open
ing
and
oper
atio
n of
a
retah
drug
outl
et o
r ot
her
similar
busi
ness
es
tabh
shme
nts
shah
no
t be
ap
prov
ed,
unle
ss apphed
for
by a
FOip
hio
regi
ster
ed an
d hcensed
phar
maci
st,
eith
er a
s ow
ner
or a
s ph
arma
cist
-in-
char
ge,
pursuant
to the
prov
isio
ns of
thi
s Ac
t.
SEC.
39.
Ha
nd
lin
g of
ph
arm
aceu
tica
l Pr
oduc
ts by
P
erso
ns
Oth
er
Th
an
a P
hfi
rmac
ist.
-
For
the
purp
ose
of th
is
sect
ion,
persons
handling
pharmaceutical
prod
ucts
, ot
her
than
the
phar
maci
st,
which
shah
incl
ude
pharmacy
owne
rs
who
are
non-
phar
maci
sts,
me
dica
l re
pres
enta
tive
s or
pro
fess
iona
l se
rvic
e representatives,
pharmacy
support
personnel,
pharmacy
tech
nici
ans,
pharmacy
assi
stan
ts,
phar
macy
ai
des,
persons
who
assi
st ph
arma
cist
s in
any
part
of a
pharmacy
oper
atio
n, or
any
othe
r pe
rson
performing
fiinctions
invo
lved
in
the
handling
of
phar
mace
utic
al pr
oduc
ts,
shah
be
duly
cert
ifie
d by
ap
prop
riat
e government
agencies
afte
r un
derg
oing
an
accr
edit
ed
trai
ning
propam.
No pe
rson
, ex
cept
ph
arma
cy
grad
uate
s,
shah
be
al
lowe
d to
render
such
services
without
undergoing
a co
mpre
hens
ive
stan
dard
ized
tr
aini
ng pr
ogra
m:
Prov
ided,
That
the
job
desc
aipt
ion
is de
fine
d in
the
impl
emen
ting
ru
les
and
regu
lati
ons
of th
is
Act.
SEC.
40.
Ad
min
istr
atio
n of
Ad
ult
Vac
cines
. —
Inadchtion
to the
requirement
prov
ided
in
Sect
ion
4, paragraph
(g)
of
this
Ac
t,
hcensed
and
trained
pharmacist
who
shall
administer
adult
vaccines
shah
ensu
re
that
the
vaccine
to b
e ad
mini
ster
ed
28
shaE
have
a do
ctor
's p
resc
ript
ion
which
is not
more
than
seve
n (7
) days
old
and
submit
a monthly
vacc
inat
ion
repo
rt and
AEFI
repo
rt t
o DOH
regi
onal
off
ices
using
the
pres
crib
ed
form.
ARTICLE
V
ACCREDITED
PROFESSIONAL
ORGANIZATION
SEC.
41.
Th
e In
teg
rate
d a
nd
Ac
cre
dit
ed
Pro
fess
ion
al
Org
aniz
atio
n (A
PO)
of P
har
mac
ists
. -
The
pharmacy
prof
essi
on
shah
bg-i
nteg
rate
d into
one
(1)
national or
gani
zati
on re
gist
ered
wi
th th
e Se
curi
ties
and
Exch
ange
Co
mmis
sion
(S
EC)
which
shah
be recognized
by the
Board
and
the
PRC
as th
e on
e and
only
in
tegr
ated
and
accr
edit
ed pr
ofes
sion
al or
gani
zati
on o
f ph
arma
cist
s.
A pharmacist
duly
registered
with
the
Board
shall
automatically
become
a member
of
the
integrated
and
accr
edit
ed
professional
organization
of
pharmacists,
and
shal
l re
ceiv
e the
bene
fits
and
priv
ileg
es
appurtenant
thereto
upon
payment
of the
reqmred
fees
and
dues
.
Membership
in
the
inte
grat
ed APO
shah
not
be
a ba
r to
membership
in
othe
r as
soci
atio
ns
of ph
arma
cist
s.
SEC.
42.
Me
mb
ers
hip
to
the
Inte
gra
ted
an
d A
ccre
dit
ed
Pro
fess
ion
al
Org
aniz
atio
n.
- Ah
regi
ster
ed ph
arma
cist
s must
be
members
of
the
APO
and
must
maintain
membership
throughout
the
duration
of the
prac
tice
of
the
prof
essi
on.
The
PIC
shah
not
be re
newe
d if
the
requirements
for
membership
with
the
APO
are
not
met
including
cred
it units
for
atte
ndan
ce
to duly
accr
edit
ed
CPD.
All
pharmacy
supp
ort
pers
onne
l must
be
regi
ster
ed
as
affi
hate
members
of
the
APO
and
must
likewise
maintain
membership
throughout
the
duration
of
employment
in
pharmaceutical
esta
bhsh
ment
s and
outl
ets.
SEC.
43.
Spec
ialty
Bo
ard
s in
Va
rio
us
Are
as o
f P
ha
rma
cy
Pra
ctic
e.
- Sp
ecia
lty
Boar
ds
in
various
area
s of
pharmacy
practice
shall
be
crea
ted,
su
bjec
t to
accreditation
by
the
Board
and
the
PRC.
The
Board
shaU
issu
e gu
idel
ines
in
the
accreditation
of
specialty
boards
in
various
areas
of
pharmacy
prac
tice
, which
shall
include
the
standards
of
29
practice
within
different
spec
ialt
ies,
qualifications,
and
requirements
for
the
certification
of
practitioners
under
each
spec
ialt
y, among
othe
rs.
ARTICLE
VI
VIOLATIONS,
ADMINISTRATIVE
SANCTIONS,
AND
PROCEDURES
SEC.
44.
Rev
oca
tio
n or
S
usp
ensi
on
of
the
Certi
ficate
o
f R
egis
trat
ion
an
d C
ance
llat
ion
of S
pec
ial/
Tem
po
rary
P
erm
it.
-Th
e Board
shah
have
the
powe
r,
upon
noti
ce
and
hearing,
to
revoke
or
suspend
the
COR
of
a registered
pharmacist
or
to
cancel
an
STP
of
a foreign
pharmacist
on
any
of
the
foho
wjng
gr
ound
s:
(a)
Violation
of any
provision
of this
Act,
it
s ru
les
and
regulations,
the
Pharmacists'
Code
of
Ethics,
Code
of
Technical
Standards
for
the
Professional
Practice
of
the
Pharmacy
Profession,
Code
of
Good
Governance
and
all
other
guidehnes,
poUcies
and
regulatory
measures
of
the
Board
and/or
the
PRC
relating
to
the
practice
of
the
phar
macy
pr
ofes
s j^
n;
(b)
Conv
icti
on of
an
offe
nse
involving
moral
turpitude
by
a co
urt
of c
ompe
tent
ju
risd
icti
on;
(c)
Unprofessionalism,
immorality,
malpractice,
inco
mpet
ence
, gross
neghgence,
or im
prud
ence
in
the
prac
tice
of
the
pr
ofes
sion
;
(d)
Fraud
or deceit
in
the
acqu
isit
ion
of th
e COR,
PIC
or STP,
or renewal
ther
eof;
(e)
Allowing
the
COR
to
be
used
or
displayed
in
esta
bhsh
ment
s where
the
pharmacist
is not
actuahy
empl
oyed
and
prac
tici
ng;
(f)
Addi
ctio
n to al
coho
hc b
ever
ages
or
to a
ny
habi
t-fo
rmin
g drug
rendering
a pharmacist
incompetent
to
prac
tice
the
prof
essi
on as
pr
ovid
ed fo
r in
Sect
ion
23
here
of;
(g)
Aiding
or ab
etti
ng t
he i
hega
l pr
acti
ce of
a
non-
regi
ster
ed
and
hcensed
pers
on;
30
(h.)
In
sani
ty or
any
mental
diso
rder
th
at would
rend
er the
pers
on incompetent
to p
ract
ice
phar
macy
;
(i)
False,
extravagant,
or unethical
adve
rtis
emen
ts
and
endo
rsem
ents
of
pha
rmac
euti
cal
prod
ucts
, ph
arma
ceut
ical
ou
tlet
s and
establishments
where
the
pharmacist's
name
or
the
pharmacist's
professional
organization
and
similar
info
rmat
ion,
or
both,
axe
used
;
(j)
Manufacture,
sale
, of
feri
ng fo
r sa
le
of
coun
terf
eit,
sp
urio
us,
substandard
and
fals
ifie
d pharmaceutical
prod
ucts
and
committing
other
acts
in
viol
atio
n of
Repubhc
Act
No.
9165
and
Repubhc
Act
No.
8203
, ot
herw
ise
loiown
as the
"Spe
cial
Law
on
Counterfeit
Drugs";
(k)
Ihegal
manufacture,
sale
, possession,
disp
ensi
ng
of
dang
erou
s dr
ugs
and
other
acts
in
viol
atio
n of
Repubhc
Act
No.
9165
, and
other
apphcable
laws
and
issu
ance
s;
(I)
Committing
acts
in
violation
of
Section
6 of
Presidential
Decree
No.
881,
entitled
"Empowering
the
Secretary
of
Health
to
Regulate
the
Labeling,
Sale
and
Distribution
of
Hazardous
Subs
tanc
es"
and
Section
11
of
Repubhc
Act
No.
3720
, as
am
ende
d;
(m)
Prac
tici
ng p
harm
acy
with
a
suspended
COR
or
e^qi
ired
PIC;
(n)
Unauthorized
disp
ens
ing
of pharmaceutical
prod
ucts
through
unre
gist
ered
on
hne
serv
ices
or
dire
ct se
ttin
g bt
isin
esse
s;
and
(o)
Being
found
guil
ty
of
immoral,
unprofessional,
or
dish
onor
able
conduct
by the
Board.
ARTICLE
VII
PENAL
PROVISIONS
SEC.
45.
Pe
na
l P
rovi
sio
ns.
-
Any
person
who
shaU
commit
any
of
the
fohowing
acts
shah,
upon
conv
icti
on,
be
sentenced
to
pay
a fine
of
not
less
than
two
hundred
fift
y
31
thousand
pesos
(P250,000.00),
but
not
exceeding
five
hundred
thousand
pesos
(P50
0,00
0.00
) or
imprisonment
of
not
less
than
one
(1)
year
and
one
(1)
day
but
not
more
than
six
(6)
year
s, or
both,
at
the
disc
reti
on of
the
cour
t:
(a)
Commissionof
any
act
in
viol
atio
n of
Se
ctio
ns
30
and
31 of
th
is
Act;
(b)
Ahowing
the
disp
lay
of o
ne's
COR
in
a pharmaceutical
establishment
where
the
pharmacist
is
not
employed
and
prac
ticu
ig;
(c)
Displaying
of
the
pharmacist's
COR
by
pharmacy
owne
Bs/o
pera
tors
in
a pharmaceutical
estabhshment
where
the
pharmacist
is n
ot
empl
oyed
and
prac
tici
ng;
(d)
Dispensing
or
ahowing
the
dispensing
or
offering
for
sale
of
prescription
drugs
or
pharmaceutical
products
in a
place
not
hcensedby
the
FDA
as a
pharmaceutical
outl
et;
(e)
Dispensing
of
prescription
and
pharmacist-only
OTC
pharmaceutical
prod
ucts
by
a
person
other
than
thos
e under
the
direct
and
immediate
supervision
of
a duly
regi
ster
ed
and
hcensed
pharmacist;
(£)
Allowing
the
disp
ensi
ng of
pre
scri
ptio
n and
phar
maci
st-
only
OTC
pharmaceutical
prod
ucts
, without
the
dire
ct
and
immediate
supervision
of
a duly
registered
and
licensed
pharmacist;
(g)
Compounding
and
dispensing
not
in
accordance
with
current
Good
Manufacturing
Prac
tice
, Good
Laboratory
Prac
tice
and
Phihppine
Prac
tice
Standards
for
Pharmacists,
and
such
other
stan
dard
s and
guid
ehne
s is
sued
by
the
Board;
(b)
Sehing
of
prescription
and
pharmacist-only
OTC
drugs
by
manufacturers,
importers,
and
wholesalers
to
unhc
ense
d pharmaceutical
outl
ets
and
other
estabhshments;
(i)
Substituting
prescription
drugs
which
are
not
gene
rica
hy
equivalent
to what
was
on
the
pres
crip
tion
, without
the
consent
of
the
prescriber
or
not
in
accordance
with
Repubhc
Act
No.
6675
;
32
© Fo
rcin
g, co
erci
ng,
or i
ntim
idat
ing
a d
viy
regi
ster
ed
and
lice
nsed
pharmacist
to
compound
or
dispense
medical
and
pharmaceutical
prod
ucts
in
violation
of
the
prov
isio
ns of
th
is
Act;
(k)
Prep
arin
g an
d co
mpou
ndin
g of
pha
rmac
euti
cal
prod
ucts
in
qu
anti
ties
gre
atly
in ex
cess
of
sing
le th
erap
euti
c do
ses,
wi
thou
t th
e presence
and
supe
rvis
ion
of a
duly
re
gist
ered
and
hcensed
phar
maci
st;
© Noncomphance
with
the
labe
hng
requirements
for
dispensed
medi
cine
s by
a
phar
mace
utic
al ou
tlet
;
(m)
Manufacturing
and
selling
of
pharmaceutical
prod
ucts
under
frau
dule
nt
name
or
addr
ess,
or
bo
th;
(n)
Adulterating
and
misbranding
of
pharmaceutical
prod
ucts
;
(o)
Manufacturing
and
sehi
ng of
uns
afe,
su
bsta
ndar
d and
coim
terf
eit
phar
mace
utic
al
prod
ucts
;
(p) Operating
an
unlicensed
pharmaceutical
outlet
such
as
online
pharmacy
service
or
direct
selling
not
authorized
by
the
FDA;
(q)
Oper
atin
g a
Cate
gory
A
esta
bhsh
ment
which
opens
for
busi
ness
without
a diJy
regi
ster
ed and
hcensed
phar
maci
st;
(r)
Operating
a Ca
tego
ry
B estabhshment
without
the
supervision
and
over
sigh
t of
a
duly
regi
ster
ed
and
hcensed
phar
maci
st;
(s)
Prac
tici
ng pharmacy
with
an
expi
red,
suspended
or
revo
ked
hcen
se;
(t)
Fill
ing
and
refi
llin
g of
pre
scri
ptio
n an
d ph
arma
cist
-onl
y OTC
pharmaceutical
prod
ucts
by
a
pers
on
othe
r than
a duly
registered
and
hcensed
pharmacist
without
the
dire
ct
and
immediate
supe
rvis
ion;
(u)
Disp
ensi
ng
pres
crip
tion
dr
ugs
and
pharmacist-only
OTC
drug
s by
ru
ral
health
unit
s wi
thou
t the
supervision
of
a du
ly re
gist
ered
an
d li
cens
ed ph
arma
cist
; and
33
(v)
Ah
othe
r ac
ts o
r om
issi
ons
anal
ogou
s to
the
fore
goin
g.
SEC.
46.
Othe
r P
enal
ties
. -
Any
pers
on who
shah
commit
any
of
the
fohowing
acts
sha
ll,
upon
conv
icti
on,
be sentenced
to
pay
a fine
of
not
less
than
one
hundred
thousand
pesos
(P10
0,00
0.00
),
but
not
exceeding
two
hundred
thousand
pesos
(P20
0,00
0.00
) or
imprisonment
of
not
less
than
thir
ty
(30)
days
but
not
more
than
one
(1)
year
, or
bot
h, at
the
disc
reti
on of
the
cour
t:
(a)
Affi
of
the
tit
le "RPh"
by a
pers
on who
is n
ot
a duly
regi
ster
ed an
d hcensed
phar
maci
st;
(b)
Prac
tici
ng t
he
pharmacy
prof
essi
on in
the
Phihppiaes
withok
a vahd
COR,
PIC
or STP;
(c)
Non-indication
of a
pharmacist
of hi
s/he
r COR
and
prof
essi
onal
tax
rece
ipt
numbers
in
offi
cial
doc
umen
ts
requiring
such
in
form
atio
n;
(d)
Refusal
to
disp
lay
the
COR
of the
pharmacist
in
a prominent
and
cons
picu
ous
plac
e in
the
esta
bhsh
ment
and
outl
et
where
the
pharmacist
is e
mplo
yed
and
prac
tici
ng;
(e)
Noncomphance
by
a duly
regi
ster
ed
and
lice
nsed
pharmacist
with
the
requirements
on
the
fhhng
of pr
escr
ipti
on;
(f)
Noncomphance
by
a duly
regi
ster
ed
and
hcensed
pharmacist
on
the
requ
irem
ents
fo
r partiahy-fihed
pres
crip
tion
;
(g)
Sehing
of p
hysi
cian
's
samp
les;
(b)
Dist
ribu
tion
of
antu
nicr
obia
ls,
incl
udin
g an
ti-T
B dr
ugs
and
othe
r pr
oduc
t cl
assi
fica
tion
as
may
be prohibited
by law
as
phys
icia
n's
samp
les;
(i)
Removal,
eras
ure
and
alte
rati
on of
mark
or label
of
phys
icia
n's
samp
le;
(j)
Use
of ci
pher
, codes,
or se
cret
ke
ys or
unusual
names
or terms
in
pres
crip
tion
s;
(k)
Fihing
of pr
escr
ipti
ons
where
ciph
er,
codes,
or secret
keys
or
unusual
names
or terms
are
used
;
34
Q.) Noncompliance
with
labeling
requirements
for
disp
ense
d me
dici
nes;
(m)
Noncomphance
with
the
requ
irem
ents
on
the
keep
ing
of r
ecor
d books
by a
pharmaceutical
outl
et;
(n)
Employment
of
personnel
in
a pharmacy
or
pharmaceutical
oper
atio
n without
the
requ
ired
tr
aini
ng
and
cert
ific
atio
n;
• (o
) Refusal
of
a non-pharmacist
owner/operator
of
a ph
arma
ceut
ical
ou
tlet
to
unde
rgo
trai
ning
and
cert
ific
atio
n;
(p)
Refu
sal
by th
e ow
ner/
oper
ator
to
aho
w and
requ
ire
duly
re
gist
ered
and
hcensed
pharmacists
and
pharmacy
supp
ort
pers
onne
l to
un
derg
o CPD,
trai
ning
and
cert
ific
atio
n;
(q)
Rendering
dispensing-related
services
by
non-
phar
maci
sts
in
a ph
arma
ceut
ical
ou
tlet
wit
hout
un
derg
oing
the
requ
ired
tra
inin
g and
cert
ific
atio
n;
(r)
Dispensing
pharmaceutical
products
in
medical
miss
ions
wi
thou
t th
e su
perv
isio
n of
a d
uly
regi
ster
ed and
hcensed
phar
maci
st;
(s)
Noncompliance
with
the
required
training
and
cert
ific
atio
n of
pro
fess
iona
l se
rvic
e or
me
dica
l re
pres
enta
tive
s or
pr
ofes
sion
al
serv
ice
repr
esen
tati
ves,
pharmacy
tech
nici
ans,
ph
arma
qy as
sist
ants
, ph
arma
cy ai
des,
ph
arma
cy cl
erks
, and
othe
r me
dici
ne ha
ndle
rs of
pha
rmac
euti
cal
prod
ucts
. Both
the
medi
cal
repr
esen
tati
ves
or p
rofe
ssio
nal
serv
ice
repr
esen
tati
ves,
ph
arma
cy
tech
nici
ans,
pharmacy
assi
stan
ts,
pharmacy
aide
s,
pharmacy
clerks,
or
medicine
handlers
and
the
pharmaceutical
esta
bhsh
ment
an
d ou
tlet
emp
loyi
ng an
y su
ch in
divi
dual
shah
be
held
join
tly
habl
e;
and
(t)
Viol
atio
n of
any
provision
of th
is Act
and
its
rules
and
regu
lati
ons
not
afor
emen
tion
ed
abov
e.
Any
pers
on,
othe
r than
the
citi
zens
of
the
Phihppines,
having
been
foimd
guhty
of any
violation
as pr
ovid
ed
for
in
this
se
ctio
n and
the
prec
edin
g se
ctio
n sh
ah,
afte
r having
paid
th
e fi
ne
or having
serv
ed the
sent
ence
, or
bo
th,
when
so
adjudged,
shah
also
be
su
bjec
t to
immediate
depo
rtat
ion.
38
The
pena
ltie
s and
habi
htie
s he
rein
pro
vide
d sh
ah b
e wi
ibho
ut
prej
udic
e to
other
sanc
tion
/s
that
may
be imposed
for
violation
of o
ther
apphcable
laws
, po
lici
es,
rules
and
regu
lati
ons.
The
owne
r/op
erat
or of
the
pha
rmac
euti
cal
esta
bhsh
ment
s/
outl
ets
and
the
duly
registered
and
licensed
pharmacists/
pharmacy
supp
ort
pers
onne
l ar
e jo
intl
y ha
ble
for
the
wUlf
ul
viol
atio
n of
any
prov
isio
n of
thi
s Ac
t.
ARTICLE
Vni
PINAL
PROVISIONS
jfSE
C. 47.
En
forc
em
en
t.
- It
shah
be
the
primary
duty
of
the
Board
and
the
PRC
to
effectively
enforce
the
prov
isio
ns
of
this
Ac
t. All
duly
cons
titu
ted
law
enfo
rcem
ent
agencies
and
offi
cers
of
the
national,
provincial,
city
or
municipal
government
or
of any
poht
ical
su
bdiv
isio
n thereof
shah
ensu
re
the
effe
ctiv
e enforcement
and
implementation
of the
prov
isio
ns
of
this
Ac
t.
SEC.
48.
Ap
pro
pri
ati
on
s. -
The
Chairperson
of the
PRC
shah
immediate^
incl
ude
in
its
programs
the
implementation
of
this
Act,
the
funding
of
which
shal
l be
charged
against
thei
r current
years'
appropriations
and
thereafter,
in
the
annual
General
Appropriations
Act.
SEC.
49.
Tra
ns
ito
ry
Pro
vis
ion
s.
- The
incumbent
Chairperson
and
members
of
the
Board
shah
, in
an
interim
capa
city
, co
ntin
ue to
function
as su
ch unth
the
Chai
rper
son
and
members
of
the
new
Board,
crea
ted
under
tlii
s Ac
t, shah
have
been
appo
inte
d and
qual
ifie
d.
SEC.
50.
Imp
lem
en
tin
g R
ule
s a
nd
Reg
ulat
ions
. -
Within
one
hundred
twenty
(120
) days
afte
r the
appr
oval
of
th
is A
ct,
the
Boar
d, subject
to
the
approval
by the
PRC,
and
in
consultation
with
the
APO,
shah
form
ulat
e and
issu
e th
e ru
les
and
regu
lati
ons
to implement
the
prov
isio
ns of
th
is Ac
t.
SEC.
51.
Se
pa
rab
ilit
y Cla
use
. -
If any
clau
se,
provision,
paragraph
or part
hereof
shah
be declared
unconstitutional
or
inva
hd,
such
de
clar
atio
n shah
not
affe
ct,
invahdate,
or impair
the
othe
r pr
ovis
ions
ot
herw
ise
vahd
and
effe
ctiv
e.
3 6
S E C . 5 2 . R e p e a l i n g C l a u s e . - R e p u b l i c A c t N o . 5 9 2 1 , a s a m e n d e d , i s h e r e b y r e p e a l e d . A l l o t h e r l a w s , p r e s i d e n t i a l d ecrees, e x e c u t i v e o r d e r s a n d o t h e r a d m i n i s t r a t i v e i s s u a n c e s o r p a r t s t h e r e o f w h i c h a r e c o n t a - a r y t o o r i a c o n s i s t e n t w i t h t h e p r o v i s i o n s o f t h i s A c t a r e h e r e b y r e p e a l e d , a m e n d e d , o r m o d i f i e d a c c o r d i n g l y .
S E C . 5 3 . E f f e c t i v i t y . - T h i s A c t s h a l l t a k e e f f e c t fifteen ( 1 5 ) d a y s a f t e r i t s p u b M c a t i o n i n t h e Official G a z e t t e o r i n a n e w s p a p e r o f g e n e r a l d r c u l a t i o n .
A p p r o v e d ,
, 0 N F E L I C I A N O B E L M O N T E J R . President o f the S e n a t e Speaker o f the H o u s e
J o f Representatives
T h i s A c t was« p a s s e d b y t h e H o u s e o f R e p r e s e n t a t i v e s a s H o u s e B i l l N o . 5 6 1 6 o n M a y 2 3 , 2 0 1 6 a n d a d o p t e d b y t h e S e n a t e a s a n a m e n d m e n t t o S e n a t e B i l l N o . 2 4 3 6 o n M a y 3 0 , 2 0 1 6 .
"'OSC^SJGZ'YABES ~ ^ M ^ [ J N B ^ A R U A ^ J P ^ ^ Secretary o f the Senate Secretary G e n e r a l
H o u s e o f Representatives
Approved:
B E N I G N O S . AQUINO H I President o f the Philippines
Lapsed snto faw on JUL t I m Without t h e s i g n a t u r e o f I h e P r e s i d e n t
5n a c c o r d a n c e v v i t h A r t i c l e V I . S e c f i o n f
Z 7 (1) of the C o n i J t a - j t i O f t